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The increasing incidence of systemic candidiasis and 
the difficulties with diagnosing the disease on the basis 
of clinical data and culture results have prompted investi-
gation into i~~unological methods of diagnosis. Detection 
of anti-candida antibodies has proved to be not sufficient-
ly specific for ~iagnosis of systemic disease since anti-
bodies are frequently found in the normal individual in 
whom the organism lives as a commensal and in superficially 
infected individuals. Our project result~d in the develop-
ment of a new quantitative immunofluorescence assay for 
quantitation of anti-candida antibodies which is able to 
differentiate quite well (p < 0.0005) between systemically 
infected patients and normals or superficially infected 
patients. We have also investigated the value of purified 
antigel1s and have shown that the use of cytopla.smic protein 
antigens rather than those containing cell wall polysaccha-
ride confers greater specificity on a q~alitative test for 
anti-candida antibodies but that a carbohydrate-containing 
antigen is adequate for differentiating systemic disease 
when a ~uantitative test is used. 
Attempts to diagnose systemic candidiasis by detection 
iii 
of circulating antigen have met with varying degrees of 
success. We were unable to detect antigen by counterirnmu-
noelectrophoresis, a quantitative immunofluorescence inhi-
bition assay, or an ELISA inhibition assay in the sera of 
rabbits in whom a Candida endocarditis was induced or in 
the sera of systemically infected patients. One postulated 
reason for this failure is the presence of the antigen in 
t.he form of circulating lmmune complexes. We have, tllere-
fore, investigated the possibility of the existence of com-
plexes containing Candida antigen and antibody in the sera 
of patients with systemic candidiasis. Using four screen-
ing tests, a statistically significant difference (p < 0.05) 
was found for immune complex levels in a group of patients 
and a group of normal individuals. Isolation and charac-
terization of immune complex-containing fractions from five 
patients with candidiasis indicated the presence of anti-
Candida antibodies and/or antigen in at least three of then). 
Therefore, these fungal in~une complexes can be assumed to 
exist and may play a role in the difficlll ties in detecting 
circulating antigen and, furthermore, may be involved in 
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Introduction 
The clinical conditions now known to be caused by the 
organism Candida albicans ha\7e been recognized for centu-
ries. Hippocrates described Iraphthae lt or white patches in 
debilitated pa.tients in llis "Epidemics II and the disease 
"thrush" was noted in Pepyst diary in 1665 (1). The oral 
lesion was recognized early as a condition of the newborn 
as well as of the debilitated and Veron in 1835 postulated 
that it was acquired during passage through the womb. Vag-
inal candidiasis was first described by Wilkinson in 1849 
and systenlic disease, acquired by hematogenous spread, was 
described by Zenker in 1861 (2). 
In 1839, Langenbeck (3) described a fungus in aphthae 
but he did not consider the fungus to be related to the 
disease. However, Berg in 1841 and Bennett (4) in 1844 
conclusively delnorlstrated the fungal etiology of thrush. 
Bennett recognized the dimorphic nature of the organism and 
irl 1847 Robin placed it in thelfgenus Oidium under the name 
oidium albicans (2). He described in detail the egg-
shaped, oval yeast cell and the mycelial form of th.e fun-
gus. In 1890, Zopf described a similar organism as Monilia 
albicans bringing confusion to the nomenclature of the 
yeast (2). Finally, in 1923 Berkhout clear'ed up the confu-
2 
sian in assigning the generic designation Candida to those 
fUIlgi which developed a pseudornycelium and reproduced by 
budding (5). 
Today, 81 species of Candida have been recognized. 
Most live as commensals in llumans, representing part of the 
normal flora of cutaneous and mucocutaneous areas. The 
most commonly encountered pathogenic species is Candida 
albicans. It is a small oval, budding, yeast-like fungus, 
2.5 by 4 by 6 ~rn, which develops a pseudomycelium by elon-
gation of cells which fail to detach (6). In sputum, tis-
sue and exudates both the budding cells and fragments of 
pseudomycelia may be seen. Other species including 
c. parapsilos, c. tropicalis, c. stellataidea, and 
c. guillermondi, are of more limited pathogenicity, al-
though they may be isolated in some of the less common but 
frequently more severe clinical manifestations of candidia-
. 
SlS. 
Candida albicans is a no~~al i~~abitant of the alimen-
tar)1 tract al1d the mucocutaneous regions in man. It i.s 
regularly present in small numbers in the mouths of normal 
healthy adults and can be found in the normal vagina of 
healthy non-pregnant women with an incidence of about 5% 
(7). The gastro-intestinal tract has a small but constant 
population of c. albicans, the number being influenced by 
the diet of the individual and by the presence of other 
members of the intestinal flora. Normal skin less cornmonly 
harbors a resident flora of c. albicans, but almost any 
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damage to skin or environmental change leads to rapid colo-
nization (8). 
In the normal host, control is maintained such that the 
number of organisms inhabiting these sites remains small 
and clinically insignificant. The balance between commen-
sal and host, however, is delicate and can be easily upset 
leading to overgrowth and to potential pathogenicity of the 
organism. Poor oral hygiene or even a small amount of an-
tibiotics may promote an increase in the number of organ-
isms in the mouth. In the adult this is usually without 
untoward results. In the newborn"however, before an oral 
ecology is established and where a low pH in the mouth may 
promote proliferation of the organlsm, even a few organisms 
presage clinical thrush (9). In older children, chronic 
thrush usually indicates polyendocrine disturbances or an 
underlying defect in natural defenses. In adults, signifi-
cant oral infection may occur as a result of mild avita-
minosis or as a complication of diabetes mellitus, advanced 
neoplasia, or the administration of steroids, antibiotics, 
or other drugs (9). 
In gravid women there is a distinct increase in clini-
cal Candida vaginitis. Pregnancy appears to affect the 
carbohydrate content of the vagina and this promotes over-
growth of tIle organism. Diabetes and antibiotic thera.py 
may also predispose to vaginal candidiasis. Candida 
balanitis or balanoposthitis may occur rarely in males, 
most often w:here there is a history of vaginitis in the 
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spouse and the condition is probably a conjugal infection 
(9) . 
It has been established that other members of the in-
testinal flora exert control over the population of c. al--
bicans in the lower intestinal tract through a number of 
mechanisms such as production of inhibitory concentrations 
of lactic acid and competition for available nutrients (1). 
Overgrowth of yeasts may occur in the young before a bal-
anced flora is established and may be associated with 
clinical symptoms such as a diaper rash following perianal 
colonization (9). In adults in whom orally administered 
antibiotics have altered the intestinal flora, overgrowth 
of the organism may lead to an irritating pruritis ani, de-
struction of the esophageal mucous membrane, or invasion of 
the gastro-intestinal mucosa. Other factors promoting 
gastro-intestinal overgrowth of the organism are diabetes, 
corticosteroid administration, irradiation, various neo-
plasias, blood dyscrasias, endocrinopathies and other de-
bilitating conditions (10). 
Overgrowth of c. albicans on the skin frequently in-
volves intertriginous areas such as the axillae, groin, in-
termammary fold, intergluteal folds, and interdigital spa-
ces. It may occur as a result of metabolic disorders or 
environmental conditions such as moisture, occlusion, or 
maceration of the skin. Chronic mucocutaneous candidiasis 
occurs in patients with genetic defects in the immune re-
sponse and in patients with polyendocrine disorders (9). 
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Besides these localized overgrowths of Candida in 
sites where the o~ganism normally lives as a commensal, a 
more significant imbalance in the forces which normally 
prevent transition from commensalism to parasitism can lead 
to dissemination of the organism to multiple internal sites 
and to a potentially lethal systemic infection. Develop-
ments in medicine since 1940 have greatly increased the oc-
currence of this imbalance of forces and the subsequent se-
vere fungal infections. 
with the onset of widespread use of antibiotics, in 
particular broad-spectrum antibiotics, the delicate eco-
system of which Candida is a member may frequently be dis-
turbed (10). Not only do antibiotics suppress the normal 
flora which acts as competition for the corrunensal Candida 
organisms, but, in addition, some damaging action by anti-
biotics on the outer layers of mucous membranes, notably 
of the intestinal tract, may facilitate the penetration of 
the organism. Should the host's resistance be impaired, 
further invasion, dissemination, and severe clini-c,~l symp-
toms may occur (11). 
The use of steroid therapy, immunosuppressive drugs, 
antimetabolites, and cytostatic drugs also affects the 
balance between host and saprophytic orga11ism. All of 
these treatment modalities, which can improve the patient's 
prognosis with respect to other disorders, may cause a sig-
nificant abrogation of the body's defenses again.st invading 
or proliferating fungal organisms. Normally, the phagocy-
6 
tic cells of the body are capable of ingesting Candida and 
the cellular response to the invader is considered the most 
important component of the defense. The organs of the body 
which have large numbers of histiocytes, for instance, 
lungs, liver, and spleen, are relatively resistent to in-
fection with Candida. On the other hand, there is evidence 
that when deep-seated Candida infections do occur, the cel-
lular response is often sluggish or lacking. Therefore, 
therapy with those agents which decrease the numbers or 
effectiveness of phagocytic cells in the body can lead to 
systemic infection and dangerous clinical symptomatology 
(12 ) • 
The practice of modern medicine has seen a tremendous 
increase in the number and extent of in~,asiv'e techniques 
undertaken to provide the patient with greater length and 
quality of life. The common use of intravenous catheters 
provides an easy entry into the body for organisms which 
are normally found on the skin (13). Hemodialysis and 
peritoneal dialysis are procedures which also brea~h the 
body's non-specific defenses and allow entry of normally 
non~pathogenic agents. One important source of entry seems 
to be 'the heart-lung machine, where Candida cells may 
easily hide and escape the procedures of disinfection so 
that on use of the machine, the fungi enter the systemic 
circulation of the patient (14). Postoperative antibiotic 
prophylaxis after heart surgery can increase further the 
likelihood that the invading Candida will ca.use dis semina-
8 
commensal Candida and the host has been upset and the fun-
gus becomes invasive, the results can be disastrous for the 
host. The disease, when untreated, can be rapidly fatal 
leading to death within a few days (18). Taschdjian et 
al., in a review, found the overall mortality rate in eight 
t 
studies containing 141 patients to be 75% (3). 
Unfortunately, the advances in medicine which have 
brought about the increased incidence of severe fungal In-
fections have not been accompanied by advances in the 
treatment of these infections. Drugs with a relatively 
high therapeutic index, such as Ketoconazole and Mycosta-
tin, have been developed for the treatment of mucocutaneous 
infections; however, the drug of choice for disseminated 
candidiasis is Amphotericin B which has a large number and 
variety of untoward effects. These include anaphylaxis, 
thrombocytopenia, flushing, generalized pain, convulsions, 
chills, fever, headache, phlebitis, anemia, anorexia l and 
decreased renal function. The most significant of these is 
the impairment of renal function which occurs in o-;~er 80% 
of persons given Amphotericin B (19). Amphotericin B must 
be administered parenterally and requires hospitalization 
and close observation throughout the period of therapy 
which is usually 6-10 weeks. 
, 
Because of the increased il1cidence of severe Candida 
infections and the frequency and severity of side effects 
associated with the treatment of choice, a method of diag-
nosing systemic candidiasis is badly needed. The physician 
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needs help in making what is a difficult therapeutic deci-
sion because, on the one hand, unnecessary toxic therapy 
should be avoided but, on the other, a delay in specific 
anti-fungal therapy in the patient with disseminated dis-
ease cannot be afforded. The problem is compounded by the 
presence of Candida as a commensal and the frequent occur-
rences of "benign" overgrowth. Differentiation between a 
superficial and a systemic infection must be made in order 
to come to a good therapeutic decision. 
In too many cases, systemic disease is not diagnosed 
until after death (20) since the diagnosis can be definite-
ly made only on the basis of histologic studies of infected 
tissue or autopsy findings. Studies have shown that only 
10-44% of cases of disseminated candidiasis documented at 
autopsy were clinically suspected or diagnosed antemortem 
(21). Cultures of body fluids, which are a major means of 
identifying other infecting organisms, are 'difficult to in-
terpret in the case of candidiasis. Part of this difficul-
ty stems from the ubiquitousness of the organism aL a ~C?m­
mensal and the frequency of its occurrence as a superficial 
pathogen. A positive Candida culture from the oral cavity, 
stool, or vagina is obviously of little diagnostic value 
since so many individuals harbor the organism at these 
sites (3). In patients on antibiotics, Candida may prolif-
erate but the mere presence of large numbers of the organ-
ism does not necessarily indicate severe infection (20). 
In a significant number of these cases either with the ad-
10 
ministration of antibiotics or with other predisposing 
causes, a fungemia is felt to represent a transient contam-
ination of the blood stream rather than seeding from a deep 
focus of infection (22). Indeed, Candida in blood cultures 
from patients with intravenous catheters may, on occasion, 
be eradicated by simple removal of the catheter (23). 
Conversely, patients with disseminated candidiasis of-
ten have negative blood cultures (24). This may be because 
of rapid clearing of Candida from the blood by the liver 
and spleen ~s has been shown in mice (25). Complement 
seems to play a role in enhancing the killing of the organ-
isms in other critical target organs such as the kidney 
(26). 
A diagnosis of systemic candidiasis on the basis of 
clinical data is likewise difficult. The manifestations of 
dissemination of Candida include chills, high, spiking fe-
ver, hypotension, and prostration, none of which can be 
considered etiologically specific (24). One clue that may 
indicate the possibility of sys·temic candidiasis is the 
presence of numerous cotton-like candidal colonies on the 
patient's oropharynx. However, since such focal growth is 
evident in patients without disseminated disease, it is on-
ly of inferential value (27). Endophthalmitis is consid-
ered to be a pathognomonic clinical sign, but it is not al-
ways present (28). 
Skin testing has also been investigated as a means of 
identifying patients with candidiasis, but, since cellular 
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hypersensitivity to Candida has been demonstrated in 45-80% 
of persons without candidal infection, skin testing has 
been largely abandoned as a means of diagnosing candidiasis 
(3). Another problem is the possibility of anergy in pa-
tients with overwhelming infection (29). 
Because of these problems with diagnosing systemic 
candidiasis on the basis of clinical data and culture re-
sults, there has been a great deal of interest over the 
past years in the development of serological tests to be 
used along with other information to reach a diagnosis. 
The detection of antibodies in the. sera of patients with 
suspected s:ystemic candidiasis has long been thought of as 
a potentially rapid and valuable diagnostic method. A num-
ber of different techniques of antibody detection have been 
tried. 
Direct slide or tube agglutination of particulate an-
tigen is one of the simplest serodiagnostic tests used in a 
variety of infectious diseases and its usefulness has been 
widely investigated with regard to candidiasis (29,30). 
The result has been that, for several reasons, agglutinin 
determinations are considered to be of little diagnostic 
value. Agglutinins have been found in the sera of 20% or 
more of healthy individuals without evidence of candidal 
infection, and there is frequent occurrence of cross-agglu-
tination with other microorganisms. In addition, complete 
absence of agglutinating antibody or insignificant titers 
have been reported in som~ 20-25% of patients with systemic 
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candidiasis (3). Increased sensitivity of agglutination 
tests ·has been achieved using latex particles (31) or red 
blood cells (32) coated with Candida antigen. 
The classical complement fixation test has been used 
in Candida serology but the test has been concluded to be 
unreliable for clinical diagnostic use and, thus, is not 
widely utilized today (33). 
Precipitation tests have been widely used to detect 
anti-candida antibodies. A tube test used by Chew and 
Theus (34) was shown to be highly sensitive but double dif-
£a-sI'orl ~'ll a.gar geLs rS-:5f r1cU5 Deell HIU.Lt:: wJ.:ueJ.Y u~t:!U .u~cc.use 
it permits discrimination of the individual precipitin re-
actions between antibodies a.nd components of the antigen 
mixture. Counterimrnunoelectrophoresis (eIE) (36) is more 
sensitive than double diffusion as well as more rapid, and 
has been recommended as a routine test for Candida antibody 
detection (37). Crossed immunoelectrophoresis has been 
used to detect and characterize anti-candida antibodies, 
providing detailed analyses of the types of precipitins 
present in patients' sera (38). Immunofluorescence tech-
niques have also been tried, using whole Candida either in 
the blastospore form (39) or the germ tube form (40), or 
using Candida polysaccharide antigens engulfed by mouse 
peritoneal rnacrophages (41). Many investigators consider 
elevated or rising titers of irroounofluorescent antibody 
more reliable for systernic candidiasis than high or rising 
agglutinin ti ters or tlle appearance of Candida precipi tins 
13 
(3,42) . 
Finally, the most recent technique suggested for de-
tection and quantitation of anti-candida antibodies has 
been enzymoimmunoassay (ELISA). (43). The results have 
been found to correlate well with immunofluorescence anti-
body titers and ELISA has an advantage in the ease with 
which numbers of samples can be run. 
The wide vari~ty of methods applied to the detection 
of anti-candida antibodies is indicative of the problems 
that remain with the serological diagnosis of candidiasis. 
Although all of the above-mentioned methods are capable of 
detecting antibodies, none has achieved a satisfactory de-
gree of specificity, particularly when the differential 
diagnosis between invasive systemic infection and superfi-
cial colonization is the main objective of serological 
studies. The commensal nature of the organism means that 
many normal individuals may have antibodies to Candida and 
many patients with superficial infections demonstrate quite 
high levels of circulating antibody. In addition, infec-
tion with fungi of several different genera may cause pro-
duction of antibodies which cross-react with Candida albi-
cans (44). On the other hand, patients who have systemic 
candidiasis may not show antibodies due to irnm.unosuppres-
sian or rapid progression to death. 
Two general approaches have been tried in an effort to 
overcome the poor specificity of the currently used tech-
niques of detection of anti-candida antibodies. One in-
14 
volves quantitation of antibody concentration and is based 
on the premise that higher titers of antibody may be asso-
ciated with systemic disease, whereas lower titers are 
found in superficia~ly infected patients and in the normal 
population (45). Furthermore, serial samples containing 
increasing titers might indicate progressive disease, while 
falling titers might occur with treatment and resolution of 
the infection. 
The second approach involves the refinement of crude 
extracts presently used as antigens in Candida serology in 
an attempt to produce a preparation that. would react spe-
cifically with antibodies found in patients with systemic 
disease. It has been claimed that antibodies to cytoplas-
mic antigen occur only in systemic candidiasis, whereas 
antibodies in normal individuals, being the result of su-
perficial colonization, are directed to the mannan of the 
cell wal·! (46). Also, it has been shown that the cross-
reacting antibodies between other fungi and Candida are 
directed to the capsular mannan (44). In spite of this, 
most of the antigens in use at present ar'e crude mixtures 
containing proteins and polysaccharides, derived from soni-
cally or mechanically disrupted Candida cells (45). For 
example/ the liS antigenU used by Taschdjian and colleagues,' 
obtained by ultrasonication of c. albicans, has been shown 
to contain cell wall material (45). 
In addition, it has been postulated that specificity 
for systemic Candida infection could be improved by using 
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antigens from the mycelial phase. As a commensal, Candida 
exists primarily as yeast, but when causing an infection 
the mycelial phase predominates (45). Antigenic stimula-
tion from both forms is presen~ in both situations, but 
there should be a quantitative difference in the antibody 
response. At the present time, most of the antigens used 
in serological testing for Candida antibodies are prepared 
from blastospores, but the use of mycelial antigens for 
routine diagnostic testing in patients with suspected sys-
temic candidiasis may give more reliable results than are 
presently obtained with yeast cell. antigens (47). 
Another approach to improving the rate of successful 
antemortem diagnosis of systemic candidiasis is through the 
serological detection of Candida antigens in patients' sera. 
This would be particularly helpful in patients who are im-
munosuppressed to such an extent that they are unable to 
produce antibodies to the infecting organisms. In addi-
tion, it is assumed that antigen would be present in pa-
tiel1ts r sera before the immunologically compete-nt patient 
has been able to mount an antibody response, and thus, de-
tection of antigenemia would allow earlier diagnosis and 
earlier treatment. Antigen detection techniques have con-
tributed greatly to the rapid, accurate diagnosis of other 
fungal and bacterial infections such as Cryptococcal (48) 
and bacterial meningitis (49), and so it has been seen as a 
promising approach in the search for a method of diagnosing 
systemic candidiasis. 
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Axelsen and Kirkpatrick (50), using crossed immunoe-
lectrophoresis, detected precipitin lines in gel containing 
sera from a systemic' candidiasis patient and antibodies to 
Candida antigen. There was a reaction of identity with 
lines in a standard antigen mixture. Weiner and Yount (51) 
developed a hemagglutination inhibition assay to detect 
Candida surface antigen, mannan. This assay detected anti-
gen in 30% of patients with invasive candidiasis and in no 
patients with non-invasive Candida or other systemic infec-
tions. Kerkering et al. (52) used eIE and detected poly-
saccharide antigen in 13 of 48 patients with cultures posi-
tive for Candida, 8 of whom were later proven to have sys-
temic candidiasis. The sensitivity in this series remained 
less than 30%. Other investigators have improved the sen-
sitivity of mannan antigen detection to approach 50% of pa-
tients with systemic disease using radioimmunoassay (RIA) 
(53) and ELISA (54). An RIA developed by stevens et al. 
(21) detects soluble cytoplasmic antigen rather than mannan 
and is said to be positive in approximately 65% of patients 
with documented disseminated disease. On the other hand, 
Lehman and Reiss (55) developed antigen detection tech-
niques using immunodiffusion, ClE, and ELISA and were una-
ble to find mannan antigen in any of the human samples they' 
tested including six with proven invasive candidiasis or in 
the serum of heavily infected and immunosuppressed rabbits. 
Jones (56) also has questioned the ability of these assays 
to detect antigen in a significant percentage of patients 
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with systemic disease. 
One postulated reason for the difficulty ln detecting 
circulating Candida antigen in the sera of infected pa-
tients is that the antigen may. be bound to antibody in the 
form of circulating immune complexes. Axelsen and Kirk-
patrick (50) noted an unusual amount of background staining 
in the gel of their crossed immunoelectrophoresis and pos-
tUlated that it might be due to high molecular weight anti-
gen-antibody complexes that did not migrate. Several au-
thors who report success in detecting circulating antigen 
have found it necessary to treat the sera before testing in 
a manner that would release antigen from antibody. Segal 
et al. (57) treated the sera with 0.5 N NaOH while Weiner 
and coats-Stephen (53) used acidification with 0.04 M ci-
trate, pH 2.7 and heat treatment. 
The presence of circulating immune complexes in other 
fungal diseases has been suggested. Geha (58) reported C1q 
precipitins in the serum of a 13 year old child during 
acute bronchopulmonary aspergillosis, but the presence of 
Aspergillus antigen in the complexes was not established. 
Bullock et al. (59) reported immune complexes in the serum 
of a patient with disseminated histoplasmosis but again the 
specific antigen was not demonstrated in the complexes. 
Yoshinoya et al. (60), studying coccidioidomycosis, not only 
demonstrated the existence of the circulating immune com-
plexes but also found them to be composed of coccidioidin 
antigen and specific antibody. These studies provide sup-
1B 
port for the idea that antigen circulating i11 patients wi th 
systemic candidiasis might be bound to specific antibody. 
Our approach to the diagnosis of systemic candidiasis 
included investigation into al.l three phases of the immune 
response - circulating antigen, immune complexes, and cir-
culating antibody. We began with attempts to develop a 
more reliable method of diagnosis using antibody detection. 
Our first approach was to use quantitative immunofluores-
cence to achieve an estimate of antibody concentration and 
to determine if higher titers are indeed associated with 
systemic disease \iliereas lower titers are found in superfi-
cial infection. Our second approach involved the study of 
the effect of the type of antigen used to detect antibody, 
be it cytoplasmic protein or cell wall polysaccharide and 
be it from the yeast or mycelial phase of growth. 
We also attempted a number of methods to detect circu-
lating free ~andida antigen both in the sera of patients 
and in the sera of rabbits with experimentally induced Can-
dida endocarditis. 
The model for experimental Candida endocarditis was 
developed by Freedman and Johnson (61) following the estab-
lis11ment of a technique for induction of staphylococcal en-
docarditis in rabbits (62,63). AI-Docry et al. (64) stud- · 
ied the pathologic changes resulting from induced left-si-
ded fungal endocarditis and found the model to closely re-
semble endocarditis in man. A number of other investiga-
tors (56,65,66) have used the model to study the pathogene-
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sis of candidiasis, and we have used it as a source of ma-
terials on which to base development of antigen detection 
methods. 
Our lack of success with these methods led us to in-
vestigate the possibility that the antigen might be bound 
to antibody and thus, that circulating immune complexes 
containing Candida antigen and specific antibody might be 
found in sera. We thus performed screening tests for cir-
culating immune complexes on a number of patients with can-
didiasis and attempted to isolate and characterize the com-
plexes found in some of them. 
Materials and Methods 
I. Patients and Normal donors 
In the development of the quantitative immunofluo-
rescence assay, serum samples from nine patients suspected 
of having systemic candidiasis on the basis of suggestive 
clinical features and positive blood cultures of c. albi-
cans were used along with samples from 43 normal donors 
with no clinical symptoms of Candida infection. The 
normal donors were divided into two groups, according to 
the presence or absence of precipitating anti-candida 
antibodies in their sera. 
In the studies using purified antigens, two 
different series of patients were used. Fifty-seven sera 
were included in series I and categorized as follows: 
Group I consisted of 17 sera obtain,ed from patients who 
had positive cultures for Candida species from non-cutaneous 
sites. These were divided into Group la, including nine 
patients with clinical evidence of systemic candidiasis 
and positive reaction when tested against a crude extract 
of c. albicans yeast by double immunodiffusion , and Group 
Ib, including eight patients with no clinical evidence of 
systemic candidiasis and negative reaction in the double 
immunodiffusion test. Group II consisted of ten sera known 
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to contain antibodies against Histoplasma and Cryptococcus. 
Group III was made up of sera from 30 healthy individuals 
without any sign of disease. It is probable that some of 
the persons in this group suff~red from subclinical mucosal 
candidiasis, since this condition is relatively frequent. 
Series II consisted of 44 patients with various 
forms of candidiasis and ten normal controls. In this 
series, we established strict criteria for a diagnosis of 
disseminated candidiasis: 1) two or more positive blood 
cultures for Candida obtained on different samplings with 
at least one positive in the absence of or after removal 
of any potential intravenous catheter source; (2) evidence 
of Candida endophthalmitis, with or without positive blood 
cultures; 3) positive culture for Candida from cerebrospinal, 
pleural, or peritoneal fluid; 4) positive culture of 
peritoneal fluid in the absence of recent abdominal surgery, 
or positive peritoneal fluid and blood cultures in the 
presence of recent abdominal surgery; 5) histologic or 
culture evidence of Candida at multiple tissue sites other 
than normal skin and mucous rnembranes. All of the patients 
in Groups I and II of Series II fit one or more of the 
cri teria described abo\Te. The seven patients in Group I had 
candidemia with multiple positive cultures and definite evi-
dence of a deep focus of infection leading to a proven diag-
nosis of systemic candidiasis. Group II consisted of five 
patients with candidemia with multiple positive cultures 
and clinical evidence leading to a probable diagnosis of 
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systemic candidiasis. Group III consisted of three patients 
with clinical evidence of systemic candidiasis but negative 
blood cultures. Group IV consisted of three patients with 
bladder or other non-invasive local infections. These 
patients had: 1) histologic or culture evidence of Candida 
at a single tissue site other than normal skin or mucous 
membranes; 2) ~ 100,000 colonies of Candida isolated from 
the urine as the sole organism on at least two different 
occasions with associated pyuria (~ 10 WBC/HPF on spun 
urine). 
Group V consisted of 17 patients with vaginal 
candidiasis. These patients met three criteria: 1) sympto-
matic vaginitis (burning, itching, and/or leukorrhea); 2) 
characteristic findings of vaginitis on pelvic examination; 
and 3) the finding of budding yeast with pseudohyphae on 
microscopic examination of 20% KOB wet preparations of 
high vaginal secretions or plaque scrapings. All patients 
who were cultured had growth of C. albicans from the 
secretions. 
Group VI consisted of nine patients with cutaneous 
or mucosal candidiasis who had Candida isolated from the 
normal skin, stool, or mouth. 
II. Animal studies 
Production of Candida endocarditis in rabbits 
Endocarditis caused by Candida albicans was 
induced in New Zealand white rabbits weighing 2 kg accord-
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ing to the method of Sande et ale (66). The right carotid 
artery was exposed and ligated and a sterile 19 gauge poly-
ethylene catheter was inserted across the aortic valve. 
The catheter was then clamped and the skin was closed over 
it. Candida infection was established by the intravenous 
injection 48 hours later of 106 Candida cells. The organ-
isms had been grown on Sabouraud's dextrose agar for 48 
hours and washed from the slants with sterile saline. Af-
ter three washes with sterile saline, the cells were 
counted in a hemocytometer and adjusted to a concentration 
of 2 x lOG/mI. 0.5 ml was injected into the margi.nal ear 
vein of each rabbit. As controls, some rabbits were 
catheterized but not infected while others were infected 
without previous catheterization. 
Collection of specimens 
Rabbits were bled prior to infection and at 
frequent intervals after infection, generally four times 
during the first week and twice each week thereafter. 
Sera was collected and stored at -20~C, and at eac}-:.. bleed 
a blood culture was done by innoculating 1 ml of blood 
into 10 ml of sterile brain heart infusion agar. The 
cultures were incubated at 37~C with constant gentle 
agitation and subcultured at one day and at one week. 
At the time of death from disease or af.ter 
sacrifice approximately four weeks post-infection, the 
animals were autopsied. Tissue samples were taken from 
heart, kidney, and other organs with gross signs of infec-
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tion for cuI t'ure and for pathologic studies. The tissue 
for culture was p1.acea. ~nt.o st.er1.l.e D01=.\:).es 01:. 'nLo.~"Il 'rl~a.i."-. 
infusioIl agar and treated as were the blood cultures. The 
tissue for pathologic studies was formalin fixed, embedded 
in paraffin, sectioned and stained with PAS. 
Sera were tested for antibody and antigen 
by coun-terimrnunoelectrophoresis and by quanti tati ve immuno-
fluorescence. 
III. Antibody Detection MeL~ods 
Immunodiffusion 
Ouchterlony double immunodiffusion (67) was 
carried out in 1% Difco (Detroit, Mich.) Noble agar pre-
pared with 0.3 M phosphate buffer, pH 8.0 (68). 
Counterimmunoelectrophoresis (CIE) 
eIE studies were carried out on 8 by 5 em 
glass plates coated with 8 ml of 1% LSA agarose (Litex, 
Accurate Chemical and Scientific Corp., Westbury, };. Y.-) 
prepared in 0.5 M barbital buffer, pH 8.6, containing 1% 
(w/v) dextran T70 (Pharmacia Fine Chemicals, Uppsala, 
Sweden). The antigen and antibody wells had a diameter of 
3 nun, an.d their closer edges ,,"'ere 4 rom apart. Each well 
was filled with 10 ~l of either antigen or antibody. The 
electrophoretic separation was carried out at 150 V for 90 
minutes. After completion of the run, the plates were 
read on a dark field illuminator, washed twice in saline, 
once in distilled water, dried, and stained with amido 
black. The readings were repeated after staining. 
Quantitative immunofluorescence (QIF) 
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Uncoated IDT stiQs were obtained from Inter-
national Diagnostic Technology (Santa Clara, California). 
These stiQs consist of a plastic handle with an immunoab-
sorbent disc affixed to a rounded tip which can be inserted 
into tubes containing test solutions and later into the 
fluorometer. The lDT stiQs were spotted with 25 ~l of 
antigen and allowed to dry at room temperature overnight. 
After drying, the stiQs were washed in 600 ~l of Tris-buf-
fered saline, pH 8.1, 'containing 0.2% Tween 20, for 30 
minutes at ,room temperature with constant shaking. After 
this wash, L~e stiQs were again dried at room temperature 
and used iwnediately or stored in a sealed box at 4~C until 
needed. 
The protocol for determination of anti-
Candida antibodies in serum samples was as follows: (a) 
serum was diluted in Tris-buffered saline, pH 8.1; (b) 
stiQs were incubated wi tll 600 IJ 1 of each serum dilution for 
30 minutes at room temperature, with constant gentle sha-
king; (c) after the incubation, the stiQs were washed for 
10 minutes in 600 IJI Tris-buffered saline at room tempera-
ture with constant shaking; (d) after the wash, the stiQs 
were incubated with 600 ~l of fluorescein-labeled antiserum 
to human irnmunoglobulins (Burroughs-Wellcome, Research 
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Triangle Park, Durham, N. C.), with constant shaking at 
room temperature, and (e) this was followed by a 10 minute 
wash in 600 ~l of Tris-buffered saline as described above. 
After the last wash, the stiQs were read in the fluorometer. 
As a control for specificity of staining, antigen-coated 
stiQs were incubated with 600 ~l of Tris-buffered saline 
instead of human serum and processed in an identical fa-
shion. 
When determination of antibody class was the 
aim of the assay, monospecific antiserum to human IgG or 
IgA (Burroughs-Wellcome, Research Triangle Park, Durham, N. 
C.) was used in the final incubation step. To assure that 
tIle monospecific al1tisera to human IgG and IgA were of 
comparable antibody titers, stiQ samplers were coated with 
25 ~l of 10 ~g/ml solutions of purified IgG or 19A and were 
incubated in 1/100 dilutions of monospecific antisera. 
Means of readings on the fluorometer of six stiQs with each 
a11tigen were compared using the Student's t-test alld no 
significant difference was found at the level of p < 0.05. 
The FlAX fluorometer (International Diagnos-
tic Technology, Santa Clara, Calif.) is a computerized in-
strument that allows quantitative readings of fluorescence. 
Light from a highly stabilized tungsten filament source pas-
ses through a narrow band interference filter whose optical 
passband is centered at 540 run, which passes only the 
fluorescent signal produced by the sample. Light is fo-
cused 011to the photocathode of a photomultiplier tube, which 
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converts the sample signals to electrical signals. The 
electrical signals are converted to a three-digit reading 
and displayed on a digital panel. 
Indirect Immunofluorescence (IIF) 
Candida albicans type A strain B385 were 
cultured in brain heart infusion agar (Difco Laboratories, 
Detroit, Mich.) pH 7.4, at 25°C (69) for 48 hours, then 
killed by the addition of formalin to a final concentration 
of 0.5%. Cells were harvested by centrifugation, washed 
with formalinized saline, and finally suspended at 1.6 x 
l06/ml in phosphate-buffered saline, pH 7.4. One drop of 
this suspension was used to make a smear which was air-dried 
and heat-fixed. A 1 em diameter circle was marked on each 
slide-. 25 ~l of serum diluted 1:5 in PBS was placed over 
the cells in the circle and the slide was allowed to stand 
in a moist chamber for 30 minutes at room temperature. 
Slides were rinsed with three changes of PBS for five minutes 
each. One drop of fluorescein-labeled anti-human :gG or 
IgA, diluted 1:20 in PBS was placed over the cells within 
the circle and allowed to stand in a moist chamber for 30 
minutes. Slides were washed as before, mounted in buffered 
glycerol, and viewed under a Leitz fluorescent microscope. 
IV. Preparation of antigens for use in antibody detection 
Antigen for i~~unodiffusion 
Whole cell preparations were made according 
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to Sweet and Kaufman (70). Cells were mechanically disrup-
ted in a hydraulic press and centrifuged at 10,000 x 9 for 
30 minutes. The final supernatant fluid, concentrated and 
adjusted to 5 mg/ml protein concentration, was used as the 
antigen in immunodiffusion studies. 
Antigens for erE and QIF 
A commercially prepared extract of Candida 
albicans, preserved in 50% glycerol, was obtained from 
Hollister stier (Division of cutter Laboratories, Berkeley, 
Calif.). For use in ClE, the antigen was diluted 1:50 in 
0.15 M phosphate-buffered saline, pH 7.2. For use in QIF 
the antigen was dialyzed against three changes of 0.05 M 
Tris-buffered saline, pH 8.1. The protein concentration 
of the dialyzed antigen was determined by the Bio-Rad 
protein assay method (Bio-Rad Laboratories, Richmand, 
Calif.), and, if needed, the protein was concentrated by 
negative pressure ultrafiltration. In the development of 
the QlF assay, the antigen was used at two concentlations, 
0.15 mg/ml and 0.35 mg/ml. Later, the standard concentra-
tion used was 0.15 mg/ml. 
Purified mycelial antigens were prepared as 
follows. A culture of c. albicans type A B385 was main-
tained on Sabouraud's dextrose agar (Difco Laboratories, 
Detroit, Mich.). Cells from this stock culture were inoc-
ulated into 100 ml of the amino acid containing medium 
formulated by Lee et al. (71) in a 250 ml Ehrlenmeyer 
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flask and rotated at 200 rpm at 15°C. When this initial 
culture reached stationary phase, at a blastospore concen-
tration of approximately 2 x loB/mI, the culture was 
diluted 1:15 in fresh medium (pH 6.5), bringing the total 
volume to two liters, and then incubated at 37~C in a 
rotating incubator (200 rpm) to induce transition to the 
mycelial phase (72). The culture was harvested by centrifu-
gation (3000 x g) and washed three times with phosphate-buf-
fered saline, pH 7.2. The washed cells were disrupted by 
three passages through a French pressure cell (American 
Instrument Company, Silver Springs, Maryland), frozen at 
-20~C, sonicated, and passed by pressure two more times, 
resulting in complete destruction of the cells (73). The 
resulting homogenate was centrifuged in three stages at 
4~C - 10,000 x g for 20 minutes, 45,000 x 9 for 30 minutes, 
and 100,000 x 9 for one hour - to produce a clear superna-
tant (74). 
The crude extract was concentrated and dia-
lyzed for 24 hours against several changes of buffer con-
sisting of 0.01 M Tris amino-methane-buffered saline, pH 
" -3 -3 ) 7.2, contalnlng 10 M caC12 and 10 M MnCl2 (73. After 
filtration through a 0.45 ~m polycarbonate membrane (Nucle-
pore, Pleasantown, Calif.), 12 ml of the crude extract was 
applied to a Sepharose-ConA (Pharmacia Fine Chemicals, 
Uppsala, Sweden) (25 ml bed volume) column. This column 
had previously been equilibrated with the same buffer. 
Chromatography was carried out at room temperature. 
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Unbound material was eluted with the equilibrating buffer. 
The material bound to the ConA was eluted with 0.2 M 
methyl mannoside in water (74). The bound and unbound 
fractions were concentrated and dialyzed against phosphate-
buffered saline l pH 7.2. The total protein concentration 
and carbohydrate concentration were determined in both 
fractions. The unbound fraction is hereafter called 
mycelial cytoplasmic antigen; the bound fraction, mycelial 
polysaccharide antigen. 
Purified yeast antigens were prepared as follows. 
Cells from the stock culture of c .. albicans A B385 were 
streaked onto slants of Sabouraud's agar and incubated for 
18 hours at room temperature. After microscopic determina-
tion that the organisms were growing in the yeast phase, 
they were washed from the slants into 300 ml of brain 
heart infusion agar in 500 ml bottles and rotated for 48 
hours at 25°C (75). 1.5 ml of formalin was added to each 
bottle and incubation continued at 25°C for six hours. 
Cultures were harvested by centrifugation at 3000 x 9 and 
washed three times with 0.5% formalinized saline. The 
final pellet was suspended at 25% (v/v) in formalinized 
saline. Purification was continued as for mycelial cells 
resulting in a yeast cytoplasmic antigen preparation and a 
yeast polysaccharide antigen preparation. 
An aliquot of. the Hollister-stier extract 
of Can.dida albicans was also purif.ied. Fifteen ml of the 
extract was dialyzed for 72 hours against daily changes of 
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distilled water. The antigen was concentrated and treated 
in the same fashion as the crude mycelial extract and then 
chromatographed on a Sepbarose-ConA column. 
The protein concentration in the various antigenic 
preparations was determined by the Coomasie blue dye-bind-
ing technique (76) (Bio-Rad Laboratories, Richmond, Calif.), 
using bovine gamma globulin as a calibration. standard. 
The phenol-sulfuric acid colorimetric method was used for 
total carbohydrate analysis (77). A standard curve based 
on a mixture of sugars was used for the guantitation of 
the carb0hydrate. 
For eIE the cytoplasmic antigen preparations 
were used at a protein concentration of 1 mg/ml and the 
polysaccharide antigen at a carbohydrate concentration of 
170 ~g/ml. For QIF the cytoplasmic antigen was used at a 
protein concentration of 0.25 mg/ml and the polysaccharide 
antigen at a carbohydrate concentration of 90 ~g/ml. 
v. Carbohydrate Analysis of C. albicans antigens 
Carbohydrates in the antigen preparations were 
further analyzed by gas-liquid chromatography. An aliquot 
of each preparation, adjusted to contain 100 ~g of sugar, 
was dried under a stream of nitrogen, then heated for 16 
hours at 65~e with 1 ml of 500 roM HCl in anhydrous methanol. 
The samples were again dried under a stream o£ nitrogen, 
and N-acetylation of the free amino groups was achieved by 
suspending the residue in a mixture of 0.1 ml acetic anby-
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dride. The samples were immediately evaporated to dryness 
and the simultaneous a-acetylation was reversed by reflux-
ing in 1 ml of 500 roM Hel diluted in anhydrous methanol 
for one hour (78). 
The constituent carbohydrates were converted to 
o-trimethyl-silyl ethers (o-TMS ethers) by treatment with 
Tri-Sil (Pierce Chemical Co., Rockford, Ill.) for 15 min-
utes at 65~C (79). The samples were then dried, and the 
o-TMS ethers dissolved in 0.5 ml hexane solution were 
injected into a varian 4000 dual column gas-liquid chromato-
graph fitted with an aV-17 column. The initial temperature 
was 90~C with a 1 minute hold, increasing 10~ per minute 
thereafter until reaching an upper limit of 250°C. This 
temperature was held for 10 minutes. Nitrogen was used as 
a carrier gas, at a flow rate of 37.5 ml/roinute. The 
separations were calibrated with o-TMS ethers of mannose 
and glucose. 
VI. Antigen Detection Methods 
Counterimmunoelectrophoresis 
eIE studies for antigen detection were car-
ried out as were those for antibody detection. 
Two different types of antibody were used 
to detect antigen. A commercial preparation of rabbit 
immunoglobulins to Candida albicans was obtained from 
DAKO-irr~unoglobulins (Copenhagen, Demnark). The antisera 
was further purified by chromatography on a DEAE-Sephacel 
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column (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibra-
ted with 0.01 M Tris-HCl, pH 7.0 (80). The column was 
eluted with 0.05 M Tris-HCl, pH 7.0 to obtain Peak I and 
then with the same buffer containing 0.25 M NaCl to obtain 
a second peak. A final wash was done with 0.05 M Tris-HCl, 
pH 7.0 with 1 M NaCl. The peaks were concentrated by 
ultrafiltration and checked for antibody activity by eIE 
and for immunoglobulin purity by immunoelectrophoresis 
(81). Protein concentration was determined by the Bio-Rad 
protein assay method. CIE showed t~at the maj,ority of the 
antibody activity was in Peak If and IEP showed that Peak 
I was pure IgG. 
Antibody was also obtained from the sera of two pa-
tients (VL and LS) with a high titer of anti-candida anti-
bodies. These sera also were applied to DEAE-Sephacel 
equilibrated with 0.01 M Tris-HCl, pH 7.0, and the peak 
containing pure IgG with maximal antibody activity was 
eluted with the equilibrating buffer. 
The limits of antigen detection by l-oth the 
purified commercial rabbit immunoglobulin and the purified 
human antisera were determined by CIE. The rabbit antibody 
at 1 mg/ml detected 500 ng/ml of Candida antigen. The an-
tibody purified from VL sera at a concentration of 0.5 mg/ 
ml detected 200 ng/ml of antigen. The antibody purified 
from LS sera at a concentration of 2 mgjml detected 200 
ngj ml of antigen. 
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Quantitative Immunofluorescence Inhibition Assay 
Uncoated IDT stiQs were spotted with 25 ~l 
of Candida antigen, a yeast extract with a protein concen-
tration of 50 ~g/ml and a carbohydrate concentration of 50 
~g/ml. After being allowed to dry at room temperature 
overnight, the stiQs were washed in 600 ~l of the assay 
buffer, Tris-buffered saline, pH 8.1 containing 0.2% Tween 
20. In the assay, stiQs were incubated for 30 minutes in 
600 ~l of one of the following: rabbit anti-candida immu-
noglobulins (DAKO) diluted 1:200 in assay buffer as the 
100% positive control; a preincubated mixture of equal vol-
umes of rabbit anti-candida diluted 1:100 and various con-
centrations of Candida antigen to establish a standard 
curve; a preincubated mixture of equal volumes of rabbit 
anti-candida 1:100 and sera to be tested. Following this 
incubation, the stiQs were washed in 600 ~l of assay buffer 
for 10 minutes at room temperature with constant shaking. 
Then, stiQs were incubated with 600 ~l of fluorescein-la-
beled sheep anti-rabbit inununoglobulins (Burroughs-Well-
come, Research Triangle Park, Durham, N. C'.) diluted 1:100 
in assay buffer for 30 minutes at room temperature. After 
a final ten minute wash in assay buffer, the stiQs were 
read in the FlAX fluorometer. 
ELISA Inhibition Assay 
A modification of the method of Segal et 
al. (57) was used. Cuvettes supplied as the solid phase 
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for the Gilford ErA Automatic Analyzer System PR-50 (Gil-
ford Instrument Laboratories, Inc./ Oberlin, Ohio) were 
coated with Candida yeast extract antigen. 100 ~l of the 
antigen diluted to a concentration of 2 ~g/ml in 0.1 M 
carbonate buffer, pH 9.6 was incubated in each test well 
of the cuvette overnight at 4~C. control wells were 
incubated with carbonate buffer without antigen. After 
this incubation, the cuvettes were washed four times on 
the processor of the Gilford EIA automatic analyzer, using 
as assay buffer, 0.15 M phosphate-buffered saline, pH 7.2 
containing 0.05% Tween 20. In the next step, 100 ~l 0f 
one of the ~ollowing was added to a cuvette well and 
incubated at 37~C for 30 minutes: PBS with Tween 20 as a 
control; rabbit anti-candida antibodies (DAKO) diluted 
1:1000 in the assay buffer as the 100% positive sample; a 
preincubated mixture of equal parts of rabbit anti-candida 
diluted 1:500 and Candida antigen at various concentrations 
to establish a standard curve; or a preincubated mixture 
of equal parts of rabbit anti-candida immunoglobulins 
1:500 and sera to be tested. After this incubation, the 
cuvettes were washed seven times with the assay buffer. 
Then, 100 ~l of horseradish peroxidase-labeled swine 
anti-rabbit IgG (Cappel Laboratories, Downington, Pa.) 
diluted 1:1000 in assay buffer was added to each well for 
a one hour incubation at 37~C. Again, the cuvettes were 
washed seven times with the assay buffer. Then, 200 ~l of 
freshly made working substrate solution was added to each 
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well. The working substrate solution consisted of 1% 
stock substrate and 0.3% hydrogen peroxide (Eckerd Corpora-
tion, Clearwater, Fla.) in 0.05 M citrate phosphate buffer, 
pH 5.0. The stock substrate was made up weekly as 0.001% 
orthophenylenediamine (sigma Chemical Company, st. Louis, 
Mo.) in methanol. After a 45 minute incubation in the 
dark at room temperature, 200 ~l of 4 N sulfuric acid was 
added to each well to stop the reaction. The color reaction 
was read by the spectrophotometer incorporated into the 
Gilford system at a wavelength of 490, and the measured 
absorbance value with a range of o.to 2.0 was printed out 
by a thermal printer. 
Sera to be tested in both types of inhibi-
tion assay were used either untreated or treated by the 
method of Segal et al. (57) to remove any bound anti-candida 
antibodies. In this method, one volume of 3 N NaOH was 
added to 5 volumes of sera and the mixture was incubated 
for 2 hours at 56~C. After centrifugation at 2000 x 9 for 
5 minutes, the supernatant was dialyzed against PBS before 
testing in the assay. 
VII. Immune Complex Studies 
Immune Complex Screening Techniques 
Direct nephelometry 
A modification of the method previously 
described by Virella et al. (82) was used. The method 
consists of determining the effects of polyethylene glycol 
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6000 (Fisher, Fairlawn, N. J.) on the immune complexes in 
the sample, assuming that an increase in light scattering 
reflects the specific aggregation of soluble immune com-
plexes. Light scattering is measured in a Hyland PDQ Neph-
elometer (Hyland Diagnostics, Deerfield, Ill.), with the 
sensitivity set at 3 and 7 (course and fine) and a final 
adjustment to obtain a reading of 170 to 190 using a ref-
erence latex suspension (0.010 ml of a suspension of poly-
styrene latex particles, 0.035 ~m in diameter (Dow Diagnos-
tics, Indianapolis, Ind.) in 10 ml of 3% (w/v) polyethylene 
glycol 6000 solution in 154 roM NaCl. The sample values 
are recorded as a percentage of the latex suspension read-
ing, after the sample blank values have been obtained. 
PEG-IgG and PEG-C 4 Tests 
These are modifications of the origindl 
procedures of Digeon et ale (83). The samples to be tested 
are incubated overnight at 4~C with 3% (wjv) polyethylene 
glycol 6000 to 0.01 M borate-buffered saline, pH 8~4. The 
resulting precipitates are washed twice in 3% polyethylene 
glycol 6000 at 4°C and resuspended in 0.4% Tween 20 in 
borate buffer and incubated at 37~C f.or 30 minutes. The 
IgG and C4 are assayed nephelometrically in both the origi-
nal serum and the resuspended precipitates. The results 
are expressed as a ratio between IgG or C4 in the precipi-
tate and the corresponding value in the serum. 
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125 1 C1q Binding Assay 
A modification of the method of Zubler 
and Lambert (84) was used. c1q was isolated by the method 
of Volanakis and Stroud (85) and labeled by the method of 
McConahey and Dixon (86). Purity was determined by double 
immunodiffusion and immunoelectrophoresis. Biological ac-
tivity was assessed by measuring the ability of the c1q to 
agglutinate IgG-coated latex (Rbeuma-Wellcotest, Wellcome 
Diagnostics Research Triangle Park, Durham, N. C.). The 
results of the binding assay were expressed as: 
%C1q binding = sam¥le value 
x 0 controls 
Ie score 
x 100 
The results of the immune complex 
screenlng tests were used individually and were compiled by 
the method of Kilpatrick and Virella (87) into an Ie score. 
This score was derived in the following manner: the mean 
value of the normal control population for a given test was 
subtracted from the value for a given sample in the same 
assay, and the resulting difference was divided by the 
standard deviation of the values obtained with the normal 
control. The mean of the corrected scores for the differ-· 
ent assays was then recorded as the Ie score. 
Isolation of Soluble Immune Complexes 
The method described by Virella et al. 
(88) was employed for the isolation of soluble immune com-
plexes. Briefly, 1 ml of 20% polyethylene glycol 6000 in 
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borate buffer was added slowly to 3 ml of serum to be ex-
amined. The mixture was allowed to stand at room tempera-
ture for one hour and at 4~C for two hours. This mixture 
was then centrifuged at 35,000 x 9 for 30 minutes and the 
precipitate was suspended in 500 roM potassium phosphate 
buffer, pH 7.5 and dialyzed against three changes of 0.1 M 
phosphate-buffered saline, pH 7.3. The sample was applied 
to a 5.5 by 34 em column of ACA -34 (LKB Instruments, Inc., 
Rockville, Maryland) equilibrated with PBS for separation 
of fractions by molecular weight. The higher molecular 
weight frac,tions were pooled and concentrated by negative 
pressure ultrafiltration and applied to a 1.5 by 10 em 
column of Sepharose 4B - Protein A (Pharmacia Fine Chemi-
cals/ Uppsala, Sweden). The column was eluted with PBS 
with the elution monitored at 280 nm. After the elution 
of the unbound protein, when the eluate had an optical den-
sity near 0, 0.2 M acetate buffer, pH 3.8 was used to 
elute the bound immune complexes. 
For the final dissociation of antigen and 
antibody, the protein eluted with the acid buffer from the 
protein A affinity chromatography column was submitted to 
a final fractionation at pH 3.8 on a 1.5 by 60 em column of 
ACA-34. 
Characterization of Isolated Immune Complexes 
Immunochemical characterization of the pro-
teins separated at different stages of the isolation proto-
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col were carried out uSlng double immunodiffusion, per-
formed in 1% Difco Noble agar in 0.02 M potassium phosphate 
buffer, pH 8.0. Anti-sera used in these studies was as 
follows: goat anti-human IgG heavy chain (Antibodies, Inc., 
Davis, Calif.); sh~ep anti-human IgM, heavy chain specific 
(Cappel Laboratories, Cochranville, Fa.); goat anti-human 
IgA, heavy chain specific (Cappel Laboratories); goat anti-
human c1q (Atlantic Antibodies, Scarborough, Maine); goat 
anti-human C3 (Cappel Laboratories); and goat anti-human C4 
(Atlantic Antibodies). 
Fractions from different stages of the iso-
lation procedure were tested for the presence. of anti-can-
dida antibodies by counter immunoelectrophoresis and by 
quantitative immunofluorescence. Candida antigen was de-
tected by counterimrnunoelectrophoresis and by the quantita-
tive immunofluorescence inhibition assay. 
YIII.statistical Analysis 
statistical analysis of the distribution of anti-
body levels as determined by quantitative immunofluores-
cence indicated skewness not consistent with a normal dis-
tribution of values. Therefore, comparison of antibody 
levels in patient and normal groups was accomplished using 
non-parametric techniques. wilcoxon's two sample test as 
extended by Mann and Whi tney to deal with une'qual-sized 
samples was used in the studies on antibody detection (89). 
In the immune complex studies data was also anal-
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yzed by the Mann-Whitney test to determine the level of 
significance of the differences between normal and patient 
popUlations. 
Results 
I. Development of the QIF Assay 
Our attempts to improve the specificity of the 
antibody detection methods of diagnosis of systemic candi-
diasis through quantitation of antibody concentration re-
sulted in the development of a new assay using quantitative 
immunofluorescence. Counterimmunoelectrophoresis was used 
as the reference technique in the development of the new 
assay. 
In our initial experiments, we determined the op-
timal concentrations of antigen and fluorescent antiserum 
for the assay. Commercial Hollister-stier antigen was used 
at this stage of the investigation. Two sera were used, 
one strongly positive and the other negative by eIE for 
anti-candida antibodies, both at a dilution of 1:20. The 
stiQs were spotted with c. albicans antigen at two differ-
ent concentrations, 0.15 and 0.35 mg/ml. The fluorescein-
labeled antiserum to human immunoglobulins was used at 
three different dilutions, 1:20, 1:50 and 1:100. The re-
sults of these experiments (Table 1) showed good differen-
tiation between the positive and negative samples at all 
combinations of antigen and antibody tested. We observed 
no fluorescent staining when antigen-spotted stiQs were in-
cubated with Tris-buffered saline instead of human serum. 
In all subsequent experiments, the antigen was used at a 
concentration of 0.15 mg/ml and the fluorescent antiserum 
was diluted 1:100. 
The objective of the next series of experiments 
was to determine whether a correlation could be est.ablished 
between different concentrations of a positive serum and 
the readings obtained with the fluorometer, keeping the 
concentrations of antigen and fluorescent-labeled antiserum 
constant. Figure 1 illustrates the correlation between the 
intensity of fluorescence and the dilution of positive 
serum. The range of dilutions 1:40 to 1:1280 was chosen to 
encompass the interval in which antibody· concentrations of 
a majority of unknown sera fell, and to reach the lower 
limit of sensitivity of the assay. The lowest dilution of 
the positive serum (1:40) was considered as 100%, and each 
following dilution was expressed as a percentage of this 
maximum. The correlation obtained (Figu.re 1) permitted 
calibration of the assay. 
When unknowns were assayed, ea·ch sample was di-
luted 1:40 and the samples were run in duplicate. The 
fluorescence readings obtained in the duplicate assays were 
converted into percentages of the posi t.ive c.ontrol. The 
results of our assays of an initial group of unknown sam-
ples and the results of erE assays of the same samples are 
shown in Table 2. The sera were grouped into three catego-
ries according to whether they were obtained from patients 
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with clinical and cultural evidence of systemic candidiasis 
(Group I) or from normal controls who were positive· (Group 
II) or negative (Group III) for precipitating antibodies to 
C. albicans as detected by eIE. statistical analysis of 
the groups by the Mann-Whitney test showed that antibody 
levels in the Group I subjects were significantly different 
from the levels of normals in Groups II and III (p < 0.01). 
Similarly, significant differences (p < 0.01) were found in 
comparisons of Groups II and III. 
Finally, we tested the reproducibility of the as-
say by repeating the determinations of five sera. Five 
tests of each sample were run ln one experiment to deter-
mine within run reproducibility. The same samples were. run 
in duplicate on five other occasions; the results of these 
repeated determinations are shown in Table 3. 
II. Use of Purified Candida Antigens 
Once this quantitative assay for anti-candida 
antibodies was developed, we redirected our approach to im-
proving the serodiagnosis of Candida toward the area of re-
finement of antigens used to detect the antibodies. 
Analysis of the Antigens 
The preparation of mycelial and yeast ex-
tracts as described in Materials and Methods provides a 
mixture of antigens in which proteins predominate over car-
bohydrates (Table 4). Affinity chromatography on ConA-
TABLE 1 
STUDY OF THE EFFECTS OF VARIATIONS IN ANTIGEN AND 
FLUORESCEIN-LABELED ANTIBODY CONCENTRATIONS ON 
THE INTENSITY OF FLUORESCENCE OBTAINED WITH 
SERUM FROM A PATIENT WITH SYSTEMIC CANDIDIASIS AND 
WITH SERUM FROM AN ASYMPTOMATIC CONTROL 




















aBoth sera diluted 1/20. The fluorescence intensity measurements are 




semi-log plot of fluorescence intensity vs. antibody 
concentration obtained with a series of doubling dilutions 
(1/40 to 1/1280) of a serum containing anti-C. albicans 
precipitates at a titer of 40 by erE. The intensity of 
fluorescence is expressed in the units given by the fluoro-
meter readouts. The antibody concentrations are expressed 
as percentages of the lowest dilution of the positive serum 
(designated as 100%). 
100 50 






a Group I 
TABLE 2 
RESULTS OF QUANTITATIVE IMMUNOFLUORESCENCE AND 
COUNTERIMMUNOELECTROPHORESIS DETERMINATIONS OF 
ANTI-CANDIDA ANTIBODIES 
b Group II Group III c 
Case no. QIF (%) eIE Case no. QIF (%) eIE Case no. 
1 >100 + 10 22.1 + 28 
2 100 + 11 11.4 + 29 
3 31 + 12 9.4 + 30 
4 22 + 13 9.0 + 31 
5 18 + 14 8.6 + 32 
6 12 + 15 8.4 + 33 
7 11 .. 4 + 16 8.4 + 34 
8 8.3 + 17 8.4 + 35 
9 5.7 + 18 7.9 + 36 
Mean 26.0 + 19 6.3 + 37 
±S.D. ±30.9 + 20 5.7 + 38 
21 5.7 + 39 
22 5.1 + 40 
23 5.0 + 41 
24 5.0 + 42 
25 3.5 + 43 
26 3.0 + 44 
27 0 + 45 
Mean 7.5% 46 







aGroup I, patients with systemic candidiasis 
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bGroup II, normals with positive precipitin test for anti-Candida antibodies. 
cGroup III, normals with negative precipitin test for anti-Candida antibodies. 
TABLE 3 
WITHIN-RUN A1~ DAY-TO-DAY PRECISION 
OF THE QUANTITATIVE IMMUNOFLUORESCENCE 
ASSAY FOR ANTI-CANDIDA ANTIBODIES 
Within-run (n = 5) Day-to-Day {n = 5) 
Mean QIF% CV% Mean QIfOk CV% 
2.98 9.4 4.36 30.96 
3.04 8.55 4.01 19.20 
5.52 13.41 8.10 40.74 
18.06 4.21 20.21 10.49 
11.76 18.45 18.63 14.65 
Mean 10.80 Mean 23.21 
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Sepharose resulted in the separation of two fractions, one 
containing the unabsorbed material washed out with the e-
quilibrating buffer (Fraction I) and the other (Fraction 
II) containing polysaccharides bound to the insolubilized 
ConA and specifically eluted with alpha-methyl mannoside. 
Chemical analysis of both fractions showed that Fraction II 
was practically devoid of protein. 
The commercially-prepared Hollister-stier antigen 
was found to be rich in carbohydrates; fractionation by af-
finity chromatography on ConA-Sepharose also resulted in 
the separation of two fractions I an unbound Fraction II 
rich in proteins and a bound Fraction II, rich in carbohy-
drates. 
The nature of the carbohydrates present in the 
crude antigen preparations and their respective fractions 
was studied by gas chromatography. These studies allowed 
the identification of glucose and mannose in all antigenic 
preparations containing detectable sugar. Representative 
profiles obtained in these studies are shown in Fi~ure 2. 
Basically, these results show that mannan is present as a 
contaminant in crude extracts and can be removed by affini-
ty chromatography using Sepharose-ConA, as previously shown 
by Longbottom et ale (73). 
Comparison of Reactions with the Various Antigens 
Using eIE 
Initial tests of sera from patients in 
TABLE 4 
CHEMICAL ANALYSIS OF THE CRUDE MYCELIAL AND YEAST EXTRACTS 
AND OF THE HOLLISTER-STIER ANTIGEN 
AND THEIR RESPECTIVE FRACTIONS OBTAINED 
BY AFFINITY CHROMATOGRAPHY ON CONA-SEPHAROSE 
Mycelial ag Yeast ag Hollister-stier 
Crude Frac Frac Crude Frac --FracCrude'Frac F'rac 
I II I II I II 
Protein 




cone. 0.75 ND 0.17 2.65 ND 0.18 1.2 0.075 0.39 
(mg/ml) 
ND - not detectable 
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Figure 2 
Gas chromatography profiles of the fractions eluted 
from ConA at neutral pH (ConA washout, Fraction I) and of 
the fractions bound to ConA, requiring elution with alpha-
methyl mannoside (ConA bound, Fraction II) from the Hol-
lister-stier antigen. The separation of two control sugars 
(mannose and glucose) is also shown. The figures under 
each peak represent the distances measured in the graph be-
tween the beginning of the recording and the a.ppearance of 
the peak. It can be seen that the major carboh:ydrate peaks 
in the ConA-bound material correspond to mannose. 
mannose 
~ '. ' . . 
Hollister-Stier extract 







series I were done uSlng eIE to compare reactions with the 
commercial Hollister-stier extract and the purified mycelial 
antigens which we theorized to be the most specific for 
systemic infection based on the belief that the mycelial 
phase predominates as the organism's invasiveness progres-
ses. Table 5 shows the results of these tests. Of 17 
culture-positive patients included in Group I, 16 were 
found to be positive by eIE using commercial antigen, 
showing a greater sensi tivi t:i7 in this test than in double 
immunodiffusion, since eight patients of Group Ib were 
negative by the latter assay. However, this high frequency 
of positive results by eIE was obtained only with Fraction 
II (polysaccharide antigen) of the mycelial extract. With 
the cytoplasmic antigen, seven of nine Group Ia patients 
with clinical indications of systemic candidiasis, positive 
cultures, arld positive results by double immunodiffusion 
test were positive , and no other patient or normal control 
showed reactivity. Of the two negative Group~ Ia patients, 
one was infected with a strain of c. tronicalis. 
* 
We also found that the ten patients in Group II with 
antibodies to fungi other than Candida whose se'ra showed 
precipitin lines when tested with Hollister-stier antigen 
reacted exclusively with the polysaccharide fraction of 
the mycelial extract. The reactivity of the 14 positive 
normal control sera was similarl~r directed to polysaccha-
ride antigens of c. albicans. 
The fractions purified from the Hollister-stier anti-
gen were tested on a more limited scale, but with similar 
results, in spite of the lesser degree of purity of these 
fractions. Of six sera tested, five were positive with the 
whole Hollister-stier antigen and one negative (Table 6). 
Of the positive sera, one was a normal donor, one was a pa-
tient with antibodies to Histoplasma, and three were pa-
tients with clinical evidence of systemic candidiasis and 
cultures positive for Candida albicans. All five sera were 
positive when tested with Fraction II (polysaccharide anti-
gen), whereas only the three from patients with suspected 
systemic candidiasis showed reactivity with Fraction I (cy-
toplasmic protein). 
To complete our initial studies r selected patients' 
sera were tested by CIE for antibodies to yeast cytoplasmic 
and polysaccharide antigens to determine if any difference 
in reactivity was present depending on the growth phase of 
the organism (Table 7). with 19 sera tested, reactions 
with yeast polysaccharide were identical with r~actions 
with mycelial polysaccharide. Three of the 19 who were 
negative with yeast cytoplasmic antigen were positive with 
mycelial cytoplasmic antigen. 
Because of these promising initial studies, further 
investigation was done on another series of patients (Se-
ries II as defined in Materials and Methods). These pa-
tients' sera were tested by counterimmunoelectrophoresis 
against the unpurified Hollister-stier antigen and against 
all four of the purified antigens prepared in our lab - the 
TABLE 5 
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RESULTS OF eIE STUDIES CO~WARING RESPONSES 
































































yeast cytoplasmic and polysaccharide antigens and the 
mycelial cytoplasmic and polysaccharide antigens. Table 8 
shows the results of erE tests on these patients' sera. 
All of the sera from the groups with proven or proba-
ble disseminated candidiasis reacted with the unpurified 
Hollister-Stier antigen but, in addition, reactions were 
obtained with two of three patients with localized infection, 
three of nine with vaginal candidiasis, four of nine with 
mucocutaneous candidiasis, and 14 of 30 normals as had 
been shown in Series I. Reaction with the yeast and 
mycelial polysaccharide antigens occurred in 11 of 12 
patients in Groups I and II but also was seen in 14 of the 
normals ·and in five of the ten in Groups III to VI who had 
reacted with the u'npurified antigen. Reaction with the 
cytoplasmic antigens was much more specific. Seven out of 
seven patients with proven systemic candidiasis reacted 
with the yeast cytoplasmic antigen and four out of seven 
with the mycelial cytoplasmic antigen. The three who did 
not react with mycelial cytoplasmic antigen all ha~ c. tropi-
calis infections rather than c. albicans. Only one patient 
in any of the other groups reacted with either cytoplasmic 
antigen. That patient had a long-standing chronic mucocu-
taneous candidiasis. An interesting additional note is 
that three of the patients with disseminated disease who 
had serial samples collected had only anti-polysaccharide 
antibodies when first studied but developed anti-cytoplasmic 
antibodies as their disease progressed (Table 9). 
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TABLE 8 
RESULTS OF eIE USING DIFFERENT ANTIGENS 
patien~ positive reactions wlth b 
Group No. H-S yc yp me 
I 7 7 7 7 4 
II 5 5 2 4 2 
III 3 1 0 1 0 
IV 3 2 0 2 0 
V 9 3 0 0 0 
VI 9 4 0 2 1 









b H-S = Hollister-Stier antigen; ¥c = yeast cytoplasmic 
antigen; ¥p = yeast polysaccharIde antigen; me = mycelial 
cytoplasmIc antigen; mp = mycelial polysaccharide antigen. 
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TABLE 9 
APPEARANCE OF ANTI-CYTOPLASMIC ANTIBODY IN 
PATIENTS WITH SYSTEMIC CANDIDIASIS 
Date Patlent LM Date Patlent LS Date Patlent ET 
Cyto Poly Cyto Poly Cyto Poly 
11/4 + 5/29 + 6/5 + 
12/19 + 6/6 + 6/11 + + 
1/6 + 6/.20 + 
1/21 + + 7/7 + 
2/23 + + 7/31 + + 
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Comparison of Reactions with the Various Antigens 
Using QIF 
Sera from 30 patients were tested by quanti-
tative immunofluorescence f.or antibodies to all of the pu-
rified antigens, and sera from 10 healthy controls were 
tested in the same way to obtain a range of normal values 
(Table 10). Patients 1-14 fit our criteria (see Materials 
and Methods) for a diagnosis of systemic candidiasis. Pa-
tients 15 - 28 had local or mucocutaneous infection and 29 
and 30 were infected with other fungi. The Mann-Whitney 
test was used to analyze differences between the mean val-
ues for the systemic, local and mucocutaneous, and normal 
groups (Table 11). 
It can be seen (Table 10) that the mean nor-
mal antibody level to the polysaccharide antigens is higher 
than that to the cytoplasmic antigens and the standard de-
viation is substantially larger. This r·eflects the pres-
ence of antibodies to cell wall mannan of yeas.ts in many 
normal individuals as was seen in our CIE data. However, 
statistical analysis (Table 11) of the difference between 
quantitated levels of antibody in the normal group and in a 
group of systemic patients showed that use of polysaccha-
ride antigens in a quantitative technique can be quite use-' 
ful in diagnosing systemic disease. The level of signifi-
cance of the difference between the two groups with the 
yeast polysaccharide antigen was p = 0.0003 and with the 
mycelial polysaccharide was p < 0.0001. 
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Comparison of Reactions with the Various Antigens 
Using QIF 
Sera from 30 patients were tested by quanti-
tative immunofluorescence for antibodies to all of the pu-
rified antigens, and sera from 10 healthy controls were 
tested in the same way to obtain a range of normal values 
(Table 10). Patients 1-14 fit our criteria (see Materials 
and Methods) for a diagnosis of systemic candidiasis. Pa-
tients 15 - 28 had local or mucocutaneous infection and 29 
and 30 were infected with other fungi. The Mann-Whitney 
test was used to analyze differences between the mean val-
ues for the systemic, local and mucocutaneous, and normal 
groups (Table 11). 
It can be seen (Table 10) that the mean nor-
mal antibody level to the polysaccharide antigens is higher 
than that to the cytoplasmic antigens and the standard de-
viation is substantially larger. This reflects the pres-
ence of antibodies to cell wall mannan of yea.sts in many 
normal individuals as was seen in our CIE data. However, 
statistical analysis (Table 11) of the differen.ce between 
quantitated levels of antibody in the normal group and in a 
group of systemic patients showed that use of polysaccha-
ride antigens in a quantitative technique can be quite use-' 
ful in diagnosing systemic disease. The level of signifi-
cance of the difference between the two groups with the 
yeast polysaccharide antigen was p = 0.0003 and with the 
mycelial polysaccharide was p < 0.0001. 
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Looking at individual patients to see if 
their quantitated antibody levels were greater than two 
standard deviations above the normal mean (Table 12) shows 
that the mycelial polysaccharide antigen was quite sensi-
tive for detecting systemic disease with 13 out of 14 pa-
tients having values above the cut-off. The one remaining 
patient had a value of 25.5, very near the cut-off of 
26.8. The yeast polysaccharide antigen was a little less 
sensitive, however, picking up nine out of 14 patients 
with systemic disease. 
Analysis of the differences between the 
systemic group and the local and mucocutaneous group again 
showed the polysaccharide antigen to be quite useful In 
the quantitative test. The level of significance of the 
difference with yeast polysaccharide was p = 0.0004 and 
with mycelial polysaccharide wa~ p < 0.0001. Analysis of 
the difference in antibody levels between the local and 
mucocutaneous group and the normals showed no significant 
difference with either of the polysaccharide antigens or 
with the mycelial cytoplasmic antigen, assuming a p < 0.05 
level to be necessary for significance. 
statistical analysis of the differences be-
tween the levels of anti-cytoplasmic antibody in the three 
groups revealed a generally less significant difference 
than was found with the anti-polysaccharide antibodies, 
with the exception that yeast cytoplasmic antibodies re-
vealed the only significant difference between the local 
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and mucocutaneous group and the normals. The level of 
that difference was p = 0.0401. The difference between 
the systemic and normal groups with yeast cytoplasmic 
antigen was significant at a level of p = 0.0089 as compared 
with the yeast polysaccharide antigen at a level of p -
0.0003. The difference with the mycelial cytoplasmic 
antigen was significant at a level of p = 0.0268 as compared 
with the p < 0.0001 level found with mycelial polysaccharide. 
The differences between the local and mucocutaneous group 
and the systemic group were not significant at a p < 0.05 
level wi t.h yeast cytoplasmic while wi th mycelial cytoplasmic 
there was significance at a level of p = 0.0409. It is 
interesting that patients 12, 13, and 14 were classified 
as systemics on the basis of multiple positive blood 
cultures but had no proven deep focus of infection, and 
these three patients had low values of anti-cytoplasmic 
antibodies as compared with the majority of the patients 
(#1-11) who had a proven deep focus of infection. Patient 
#11 who also had low anti-cytoplasmic antibodies hcd a 
very rapid progression to death f.rom the beginning of his 
disease. Looking at Table 12, these four patients and one 
other were the only five systemic patients who did not 
have levels greater than two standard deviations above the 
normal mean with mycelial cytoplasmic antigen. 
Patients 29 and 30 who had other fungal in-
fections and who had anti-polysaccharide antibodies by eIE 
did not have antibody levels greater than two standard de-
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viations above the normal mean against any of the antigens 
when tested quantitatively. 
III. Use of QIE to Determine Antibody Class 
The quantitative immunofluorescence assay which 
had been developed by us and used to measure concentrations 
of antibody to various types of Candida antigen could be 
modified for other uses as well. One which was investigated 
was the determination of class of antibody, which would be 
easily accomplished by changing the specificity of the 
fluorescent antisera so that antibodies of only one class 
would be determined. This modification was used to test 
the hypothesis that superficial forms of Candida infection 
might lead to the production of antibodies of the IgA 
class in higher titer than, or to the exclusion of, other 
classes of antibody due to the association of IgA with 
mucosal epithelium. It was hoped that, if this were true, 
it might aid in differentiation between superficial and 
deep-seated infections. Earlier studies on this question 
(32, 90) had been done using an indirect immunofluorescence 
test on smears of Candida albicans cells and had lead to 
conflicting results. 
We used our group of vaginal candidiasis patients 
(see Materials and Methods for diagnostic criteria) and 
tested the sera first for precipitating antibodies to the 
Hollister-stier extract of c. albicans and to purified 
cell wall polysaccharide since that antigen is the primary one 
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TABLE 10 
RESULTS OF QIF STUDIES OF RESPONSES TO CYTOPLASMIE 









































































































a See text for identification of patients. 
,b Underlined values are greater than 2 standard deviations 
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Cyto Poly Cyto Poly Cyto Poly Cyto Poly 
0.0089 0.0003 0.0268 <0.0001 0.0655 0.0004 0.0409 <0.0001 
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detected in the indirect immunofluorescence test which had 
previously been used in these studies. Three out of 17 pa-
tients in the vaginal candidiasis group showed precipita-
ting antibodies to the commercially prepared extract but 
none demonstrated precipitating antibodies to purified man-
nan. 
Quantitative immunofluorescence, using polyvalent 
antisera to human immunoglobulins, was used to test the se-
ra of 16 patients with Candida vaginitis for antibodies to 
the purified yeast polysaccharide antigen. Table 13 shows 
the detected levels of antibody, expressed as a percentage 
of the maximum reading found with a highly positive control 
sera, and the mean level found in ten normal controls. 
statistical comparison of the antibody levels in the pa-
tient and normal groups 1 using the Mann-Whi tlley test, 
showed that the means of the two groups differed at a level 
of p - 0.0778. If P < 0.05 is chosen as the level neces-· 
sary for statistical significance, the antibody levels in 
these two groups do not show a significant differer~ce. 
Eight of the patients had antibody levels greater 
than one standard deviation above the mean level of the 
normal controls (that is above 15%). Quantitation of anti-
body of the IgG class and the IgA class was done in these 
patients using monospecific antisera to human IgG and IgA 
in the fluoroimmunoassay. Results (Table 13) showed the 
antibody to be predominantly IgG in all cases. 
Indirect immunofluorescence was done on these 
bY 
same eight sera, with the serum from a systemic candidiasis 
patient used as a positive control and serum from a normal 
individual used as a negative control. The intensity of 
fluorescence with fluorescein-labeled anti-human IgG fol-
lowing incubation with a vaginal candidiasis patient's 
serum was indistinguishable from the intensity with the 
systemic candidiasis patient's serum (Figure 3). Intensity 
with fluorescein-labeled anti-human IgA was definitely 
less than that with anti-IgG, and less than that of the 
systemic candidiasis patient with anti-IgA. The normal 
showed only a trace. of fluorescent staining with anti-IgG 
and was negative with anti-IgA. 
These studies on vaginal candidiasis patients 
served not only to support the earlier data (90) that had 
indicated that anti-candida antibodies in vaginal candidia-
sis patients were predominantly IgG but also to demonstrate 
the usefulness of the QIF assay to achieve a number of 
different goals in antibody detection. Not only can the 
presence and concentration of antibody be determined, but 
their class is easily defined as well. 
IV. Antigen Detection Studies 
Having completed these studies of detection of 
antibodies to Candida albicans, our attention was turned 
to attempts to detect circulating antigen. 
In order to have sufficient amounts of sera, 
which should contain circulating antigen, for the investi-
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TABLE 13 
RESULTS OF STUDIES USING QUANTITATIVE IMMUNOFLUORESCENCE 
AND INDIRECT IMMUNOFLUORESCENCE TO DETERMINE LEVELS AND 
CLASS OF ANTI-CANDIDA ANTIBODIES IN VAGINAL CANDIDIASIS 
PATIENTS 
QIF lIE 
TOTAL IgG IgA IgG IgA 
PATIENT ANTIBODY ANTIBODY ANTIBODY 
P.B. 6.1% N.D. (1) N.D. N.D. N.D. 
s.s. 36.3% 15.2% 8.6% 3+ 2+ 
R.P. 0.3% N.D. N.D. N.D. N.D. 
D.B. 8.0% N.D. N.D. N.D. N.D. 
S.G. 7.3% N.D. N.D. N.D. N.D. 
M.D. 6.6% N.D. N.D.· N.D. N.D. 
H.M. 16.7%~ 7.5% 4.5% 3+ 1+ 
c.w. 17.3%* 6.2% 1.2% 3+ 1+ 
C.H. 14.7% N.D. N.D. N.D. N.D. 
G.B. 4.9% N.D. N.D. N.D. N.D. 
P.D. 27.7% 14.6% 4.3% 3+ 1+ 
M.E. 18.7%* 10.3% 5.2% 3+ 1+ 
A.C. 20.3% 10.7% 3.4% 3+ 1+ 
C.M. 17.7% 8.5% 2.7% 2+ 1+ 
M.B. 23.3% 11.1% 5.2% 3+ 1+ 
W.B. 4.7% N.D. N.D. N.D. N.D. 
Mean 14.7% 10.5% 4.4% 
Standard Deviation 9/4% 3.2% 2.2% 
(2 ) 
Mean o.f 10 Normals 9.4% 
Standard Deviation 5.5% 
(l)N.D. = Not Done 
(2)Three were positive by eIE; the sera from an asymptoma-
tic donor found to have high antibody titers was not 
included in this series. 
(*)Positive by eIE. 
71 
Figure 3 
Indirect immunofluorescence on C. albicans cells: 
(A) sera of a systemic candidiasis patient followed by 
fluorescent anti-human IgGi (B) sera of a systemic candidi-
asis patient followed by fluorescent anti-human IgA; 
(e) sera of a vaginal candidiasis patient followed by 
fluorescent anti-human IgG; (D) sera of a vaginal candidia-
sis patient followed by fluorescent anti-human IgA. 
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gation of these assays, Candida endocarditis was induced 
irl 13 rabbits as described in Materials and !'1ethods. Nine 
were infected with 106 Candida cells, two with 107 and two 
with 108 . Rabbits were bled prior to infection, four at 
2~ hours post-infection, and all on days one and two 
post-infection and every two to three days thereafter 
until death or sacrifice. To determine the extent of 
infection achieved in these rabbits, blood cultures were 
done each tinle the rabbi ts were bled and tissue was cuI tured 
and examined grossly and microscopically at death or 
sacrifice of the animals. Table 14 summarizes the culture 
and pathology results. All blood cultures were negative 
except the samples drawn at 2~ hours post-infection. Four 
out of four rabbits cultured at this time grew out yeasts 
that were too numerous to count on the culture plate. 
Gross examination of the hearts of the animals revealed 
vegetations on the aortic valves and/ or the ventricles of 
all rabbits except one which died two days post-infection. 
Another which died within 24 hours showed damage to the 
valves but no truly significant vegetations. Figure 4 
shows a vegetation from the left ventricle of one of the 
infected rabbits. Gross examination of the kidneys revealed 
microabscesses and/or infarcts in all animals except the 
ones which died within 24 hours and at two days. Eight of 
the 13 rabbits had positive cultures from the cardiac 
vegetations and nine had positive cultures from the kidneys. 
Microscopic evidence of Candida growth was seen on sections 
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taken from the hearts of six rabbits. Figure 5 is an 
example of what was seen. Microscopic evidence of Candida 
growth was seen on sections taken from the kidneys of 
three animals. Figure 6 is an example of a rabbit kidney 
in which organisms are seen in tubules. 
From the evidence shown above, it seems obvious 
that at least 10 of the 13 rabbi ts in whom indl1ction of 
Candida endocarditis was attempted developed disseminated 
disease. Therefore, their sera should have provided a 
good source of material in which to detect circulating 
antigen. We used counterimmunoelectrophoresis as described 
in Materials and Methods to test each sample from these 
rabbits and were unable to detect antigen in any of them. 
In addition, the QlF inhibition assay for antigen was used 
to test some samples. A standard curve as seen in Figure 
7 was obtained wi th a kno·wn antigen solution, but no 
samples of rabbit sera showed any inhibition at all. 
A limited number of patient samples were tested 
for antigen by ClE, QlF inhibition, and ELISA inhibition. 
Eight were tested by elE including five classified as 
having systemic candidiasis and three with local or mucocuta-
neous candidiasis. No antigen was discovered in the sera 
of any of these patients, although elE showed one patient 
to have antigen present in his joint fluid. 
The QIF inhibition assay was used to test the 
sera of 12 normals and eight patients including four 
classified as having systemic candidiasis and four with 
TABLE 14 
CULTURE AND PATHOLOGY RESULTS ON RABBITS INFECTED WITH 
CANDIDA ALBICANS 
Microscopic 
Gross Organ Culture Presence of 
No. of Days Lived Involvement Results Organisms 
Infecting Post 
Kidney Kidney Heart Kidney Rabbit organisms Infection Heart H~art 
1 108 1 + - + + 
2 108 7 + + + + + 
3 107 21 + + + + 
4 107 21 + + + + + 
5 106 2 - -
6 106 29 + + + + 
7 106 18 + + + + + + 
8 106 24 + + - -
9 10
6 29 + + + + + 
10 106 31 + + + + + + 
11 106 32 + + + + 
12 106 38 + + 
13 106 29 + + - + 
Figure 4 
Left ventricular vegetation seen in a rabbit injected 
with 106 Candida albicans cells. 
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Figure 5 
Candida organIsms seen In a microscopic section of a 




Kidney section from a rabbit infected with 106 Candida 
albicans cell. 
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local or mucocutaneous infection. These sera were all 
treated as described in Materials and Methods to break up 
any antigen-antibody complexes and destroy any free antibody. 
For each sera a control was run to be certain that no free 
antibody remained to interfere with the inhibition assay. 
The percentage irlhibition of each sera can be seen in 
Table 15 and comparison of the normals and patients reveals 
no signif.icant difference. Antigen waSt therefore, undetec-
table in L~ese samples by this method. 
The ELISA inhibition assay was used to test ten 
Ilormals and these same eight patients. The sera were 
treated as above. An inhibition curve with standard 
amounts of antigen can be seen in Figure 8. The amount of 
inhibition seen with normals and patients is seen in Table 
16. Again the difference between patients and normals was 
insignificant and no antigen could be detected by this 
method. 
We also tried to determine the effect of the sodium 
hydroxide treatment on c. albicans polysaccharide antigen. 
For this serial dilutions of purified antigen were added 
to a fixed volume of normal human serum and the mixture 
was submitted to the treatment as suggested by Segal, et 
al. (57) and described in Materials and Methods. When the 
treated mixture was tested in the QIF inhibition assay, 
the standard inhibition curve normally seen with such 
serial dilutions of antigen was not obtained. 
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TABLE 15 
RESULTS OF THE QIF-INHIBITION ASSAY FOR ANTIGEN DETECTION 
Normals % Inhibition Patients a % Inhibition 
1 10.7 1 0 
2 5.8 2 0 
3 0 3 0 
4 2.9 4 2.1 
5 0 5 5.2 
6 0 6 10.3 
7 1.0 7 17.5 


















RESULTS OF THE ELISA INHIBITION ASSAY 
FOR ANTIGEN DETECTION 
Normals % Inhibition Patients a % 
1 5.3 1 
2 0 2 
3 0.5 3 
4 0 4 
5 11.8 5 
6 11.2 6 
7 11.8 7 
8 12.3 8 
9 11.0 
10 15.3 
a Patients 1-4 
candidiasis. 












v. Immune Complex Studies 
Because of the lack of success with these antigen 
detection techniques, our attention was focused on investiga-
tion of the possibility that circulating immune complexes 
might be present in the sera of systemic candidiasis pa-
tients and that they might be interfering with antigen 
detection. Sera from eleven patients in our group with 
disseminated candidiasis and from 18 normal cont.rols was 
tested by four immune complex screening tests - the Direct 
Laser Nephelometry test, the PEG-C4 , the PEG-IgG and the 
C1q tests. The scores on the individual tests were com-
pared for the two groups and, after the individual scores 
were compiled into Ie scores, those, too, were compa.red 
for the two grQups. A statistically significant difference 
(p < 0.05) was found between the patient and normal popula-
tions for three of the four screening m~thods (all but the 
c1q assay) and with the Ie scores (Table 17). 
with the results of these screening tests sub-
stantiating the existence of circulating immune cor~~plexes 
in the sera of patients with systemic candidiasis, attempts 
were begun to isolate and characterize the complexes from 
several patients. 
Sera from four patients from our group with 
systemic candidiasis, from one patient with a severe and 
chronic mucocutaneous candidiasis, from one normal individual, 
and from aIle patient wi th vasculi tis who had high immune 
complexes and no sign of any Candida infection were analyzed. 
85 
Immune complexes were isolated as described ln Materials 
and Methods_ A characteristic profile from an ACA 34 sep-
aration of the PEG precipitate of the sera of a patient 
with systemic candidiasis is shown in Figure 9. Peaks 1, 
the high molecular weight peak, and 2, the low molecular 
weight peak/ were pooled and analyzed for the presence of 
Candida antigen/ anti-Candida antibodies, IgG, IgM/ IgA, 
cIg, C3 , and c 4 - The high molecular weight peak was 
applied to a Sepharose 4B-Protein A column and eluted 
first with PBS to obtain the bound protein fraction. The 
bOl1nd fraction was assumed to contain IgG which had stuck 
to the Protein A. An elution profile is seen in Figure 
10. These fractions were analyzed as had been the ACA 
peaks. 
Table 18 shows the results of the analysis of 
the isolated fractions of patient and control sera. 
Samples 1-4 were obtained from patients classified by our 
criteria as having systemic candidiasis. Sample 5 was 
from a patient wi th severe and chronic mucocutaneol"'_S 
candidiasis. Sample 6 was obtained from a normal individual 
with no sign of any Candida infection. Sample 7 was from 
a patient with vasculitis who had elevated circulating 
immune complexes but no evidence of Candida infection. 
Analysis of the sera of all the investigated individuals 
showed no evidence of antigen by counterimmunoelectrophoresis 
but antibody was present in all sera except the normal 
individual by both eIE and quantitative immunofluorescence. 
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TABLE 17 
LEVELS OF CIRCULATING IMMUNE COMPLEXES IN SYSTEMIC 
CANDIDIASIS PATIENTS BY FOUR SCREENING TECHNIQUES 
(DIRECT NEPHELOMETRY, c1q ASSAY, AND A COMB lNED 
C~ ASSAY AND IgG ASSAY) 
SORE 
Patlent DL C1q C4 IgG IC Score 
1 17 79.1 42 0.45 3.1700 
2 18 99.5 41 0.70 2.6367 
3 4 109.2 28 0.30 0.7756 
4 8 75.6 0.64 1.6741 
5 5 42 0.45 2.27.91 
6 8 138.0 35 0.22 1.8800 
7 12.5 110.0 23 0.42 1.9611 
8 6 89.9 34 0.78 3.1686 
9 0 101.6 39 0.39 0.9762 
10 0 105.0 20 0.77 1.3651 
11 5 126.8 0 0.13 0.0084 
Mean of the 
Patients 7.59 103.47 30.4 0.48 1.8086 
Mea.n of 18 
Normals 2.3 100.0 19.23 0.21 0.0433 




and Normals 0.0057 0.1635 0.0068 0.0001 <0.0001 
87 
~~en the ACA 34 peaks were analyzed, anti-candida antibody 
was found in the low molecular weight fraction of all 
those examined except the normal and sample 7 and in the 
high molecular weight fraction of all except the normal 
and sample 1. Sample 1 was the first sera tested and was 
less extensively analyzed, having been tested for antibody 
only by CIE, which is less sensitive than QIF, and having 
not been analyzed for immunoglobulin or complement compo-
nents. Analysis of the ACA peaks by CIE for antigen, 
however, revealed its presence in the high molecular 
weight fractions of samples 2 and 5 and in the low molecular 
weight fractions of samples 1 and 2. Figure 11 is a 
photograph of the CIE plate testing sample 2's fractions 
for antigen. 
Analysis of the ACA 34 fractions for immunoglobu-
lin and complement components was done by immunodiffusion. 
The analysis of sample 4 is shown in Figure 12 as an exam-
ple. The three systemic candidiasis patients tested, the 
mucocutaneous patient, and the patient with vascul~tis all 
had three immunoglobulin classes present in the high 
molecular weight fraction while the normal individual had 
evidence only of IgM. Complement components were found In 
the high molecular weight fraction only in the patients 
with systemic c~ldidiasis. 
Analysis of the bound and unbound fractions from 
the Protein A column separation of the high molecular 
weight peaks of each sera revealed antibody in the bound 
fraction only of samples 2, 3, and 5, two of which were 
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Figure 9 
Elution profile from ACA 34 column of 5% PEG precipi-
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Figure 10 
Elution profile from a Sepharose 4B Protein A column 
to which the high molecular weight fraction of sera from a 
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TABLE 18 
RESULTS OF THE ANALYSIS OF FRACTIONS OF PATIENT 
AND CONTROL SERA ISOLATED FOR II~NE COMPLEXES 
Fractions Sera ACA-34 high mol. wt. frac. ACA-34 low mol. wt. frac. Protein A bound frac. Protein A unbound frac. 
Samplea~Ag~Ao'Ag~~Ao----G' M-~-A--CIq~t3'~C~4--Ag-~-Ab-~ G M A Cl(iC3-~-C4-Ag-AbG-M A 'Clq C3 C4 Ag Ab G M A Clq C3 C4 
1 - + + + + 
2 + + + + + + + + + + - + + - + + - - - + - + + + - - + 
3 - + - + + + + + + + - + + + - + - - - + - + - + - - -
4 - + + + + + + + + - + + + + + - + + + + - + -
5 - + + + + + + + + + + + - + + + + + + + + + 
6 + - + - + + + - - - - - - -
7 - + + + + + + - - - - + - + + - + 
a Samples 1-4 were from patients diagnosed as having systemic candidiasis. 
Sample 5 was from a patient with severe and chronic mucocutaneous candidiasis. 
Sample 6 was from a normal indiuidual. 




from systemics and one from the mucocutaneous patient. 
Antibody was found in the unbound fraction of samples 3 and 
4 from systemics and in the sample from the patient with 
vasculitis. The latter fact, along with the evidence of 
IgM and IgA in sample 7's unbound fraction but not IgG, 
made it seem that the antibody to Candida which had ap-
peared in his high molecular weight peak might have been 
19M rather than an immune complex. Antigen was found in 
the bound fraction from samples 2 and 5 and in the unbound 
fraction of samples 1 and 2. Immunoglobulins G, M, and A 
Here detected in the bound fraction of sample 5 and G and M 
were found in the bound fraction of sample 4. Immunodiffu-
sion may not have been sensitive enough to detect the 
w~ount of immunoglobulin in sample 2 although more sensi-
tive methods could detect specific antibody. c1q was de-
tected in the bound fraction of samples 3 and 5 and C4 also 
in s~~ple 3, further substantiating the existence of immune 
complexes in these patients. The unbound fraction from 
samples 2 and 4 contained G, M, and A and C4 in san.pIe 2 
and C3 in sample 4. 
The Protein A-bound fraction in sample 5 which 
had been found to contain both antigen and antibody was 
applied to another ACA 34 column, this time equilibrated 
and eluted in an acid buffer to try to keep the antigen and 
antibody dissociated. The profile can be seen in Figure 13. 
Antibody was found in Peak II by QIF and antigen was found 
in Peaks III and V by CIE. A reproduction of this eIE 
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Figure 11 
Counterimmunoelectrophoresis testing ACA 34 fractions 
from a patient with s:ystemic candidiasis for Candida antigen .. 
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Figure 12 
Immunodiffusion to determine the immunoglobulin and 
complement component content of the ACA 34 fractions from 
the sera of a patient with systemic candidiasis. 
Anti-G 
PeakI 
Anti-A Anti-M Anti-C3 Anti-C4 
Anti-G 
Peakn 
Anti-A Anti-M Anti- C3 Anti-C4 
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Figure 13 
Elution profile of the separation on an acid ACA-34 
column of the Protein A bound fraction from the high 
molecular weight peak of a sera from a patient with severe 









counterimmunoelectrophoresis plate showing the detec-
tion of antigen in tb.e eluted tractions from the acid-ACA-34 

















plate can be seen in Figure 14. 
The results of the data on separation and 
characterization of immune complexes, though not totally 
consistent wiL~ respect to the finding of antigen and anti-
body in high molecular weight fractions of all sera, cer-
tainly suggests that complexes consisting of Candida anti-
gen and antibody do exist in the sera of some patients. 
Discussion 
The value of the serological methods of diagnosing 
disseminated candidiasis has been a point of controversy 
since the first reports of detection of anti-c,andida anti-
bodies in patients with systemic disease prompted hopes 
that the presence of these antibodies could lead to a de-
finitive diagnosis. Initially, the most commonly used 
tests were for agglutinating antibodies. Agglutinins are 
found in a high percentage of individuals with systemic 
candidiasis but they also occur in a large percen,tage of 
individuals without evidence of Candida infec.tion. Winner, 
in 1955, (91) found agglutinins in 31.6% of 2,017 hospital 
patients and Scuro and Perrone in 1959, (9~) found an inci-
dence of 42.1% in 301 subjects without evidence of candi-
diasis. Agglutinating antibodies may be found in Even 
higher percentages of patients with superficial forms of 
Candida infection. 80% of patients with chroni..c mucocu-
taneous candidiasis were found by Lehner et al. (42) to be 
positive when tested for Candida agglutinins. Complement-
fixing antibodies have likewise been found in high percen-
tages of normals and superficially infected patients. In 
the group of 301 normals tested by Scuro and Per'rone (92), 
30.6% were positive by complement fixation and in a group 
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of 48 patients with Candida skin infections tested by Peck 
et ale (33), 75% were found to be positive. 
Indirect fluorescent antibody to Candida has been 
found less frequently in normal individuals. In six 
series of healthy donors (39, 93, 94, 95, 96, 97), only 
two (39, 97) reported any incidence of positive reaction 
and those were 18.8% and 16.0% respectively. Among pa-
tients with superficial forms of candidiasis, however, 
percentages were much higher - 64% in a series of 75 
patients with oral candidiasis (93) and 51.4% in a series 
of 37 with oral infections (95). 
Precipitating antibodies have generally' been found to 
be more specific for systemic candidiasis. A number of 
authors (39, 94, 97, 98) claim to have found no positive 
reactors in normal individuals. Others, however, have 
found a low incidence - 10.4% of 604 individuals in a 
study by Douchet and Muller (99) and 3.7% of 191 individu-
als in a study by Everall et ale (100). In patients with 
superficial forms of candidiasis, again, the incidence of 
positive reactors is high in some studies. Stanley and 
Hurley (101) found 34.4% of 125 pregnant women with vaginal 
candidiasis to have Candida precipi tins in, th.eir sera. 
Taschdjian et al. (102) found an incidence of 25.5% 
positives in 51 subjects with superficial candidiasis. 
Questioning the value of these antibody detection 
tests, therefore, appears to be justified in light of 
their lack of specificity for systemic candidiasis. A 
better means of identifying<·~'the individuals w'r1i!tc .. deep-seated 
infection, who must be treated aggressively, is obviously 
needed. 
Several authors have noted that quantitation of anti-
body concentration may be a means of achieving greater 
differentiation between groups with and without systemic 
candidiasis. In agglutination, complement fixation and 
fluorescent antibody assays, results are usually reported 
in terms of titers. Seeliger (103) noted that agglutinins 
found in healthy individuals rarely exceed a titer of 
1:160. Coudert et al. (94) failed to demonstrate titers 
greater than 1:40 in 217 individuals including 17 with 
superficial candidiasis and 62 with noncandidal infections. 
Taschdjian et ale (3) have summarized the results of five 
studies (39, 42, 93, 94, 104) with indirect fluorescent 
antibody and found that titers greater than 1:160 are 
rarely encountered in healthy individuals. 
The development of the quantitative immunofluorescence 
assay 'provided a means of objective measurement of anti-
Candida antibodies whereby the hypothesis could be tested 
that higher titers of antibody are associated with systemic 
disease, whereas lower titers are found associated with 
superficially infected patients and normal individuals 
(45). Results in two series of patients included in these 
studies suggest that this hypothesis is valid. In the 
series of patients tested in the initial studies where a 
commercial yeast extract was used as antigen, a difference 
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between mean antibody levels in the group of systemic pa-
tients and the group of normal controls was found to be 
significant at a level of p < 0.01. In the series of pa-
tients tested against purified cell wall polysaccharide 
antigens, the QIF assay was able to differentiate between 
systemic patients and normals and, more importantly, be-
tween systemic patients and those with a superficial 
infection at a level of significance of p < 0.0005. If a 
value greater than two standard deviations above the 
normal mean is considered as a positive test, none of the 
normals is positive when tested against ei the.r polysaccha-
ride antigen while only one of the superficially infected 
patients is positive with yeast polysaccharide antigen and 
three are positive with mycelial polysaccharide. 
The QIF assay could, therefore, offer a significant 
improvement in specificity in the diagnosis of systemic 
candidiasis through quantitation of antibody. 
Another value of the QIF assay lies in its easy 
adaptation for the detection of class of antibody. We 
were able to use the assay to test the hypothesis that 
superficial forms of Candida infection involve the predomi-
nant production of IgA antibodies rather than. IgG. Earlier 
studies by Mathur et al. (32) using indirect immunofluore-
scence on smears of Candida cells to test the sera of 
vaginal candidiasis patients had suggested that this was 
the case. Warnock et al. (90), however, using the same 
technique, disputed these findings and showed that the 
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distribution of antibody In vaginal candidiasis patients' 
sera was similar to that in systemic patients - that is, 
predominantly IgG. Our studies using QIF and indirect 
immunofluorescence have confirmed the latter findings. 
The differences in these studies may, possibly, be due to 
differences in patient selection or to differences in the 
specificity of the antisera. In any event, it seems 
evident that the initial impression that the assay of IgA 
anti-candida antibodies could be of value in the diagnosis 
of vaginal candidiasis cannot be sustained in light of the 
present data. 
Another suggested means of differentiating between 
systemic candidiasis patients and other groups has been 
tIle detection of antibodies to purified components of 
Candida organisms. Observations on the rapid phagocytosis 
and breakdown of Candida organisms injected intravenously 
(35, 105), assumedly resulting in the release of Candida 
cell contents, have prompted the idea that antibodies to 
cytoplasmic proteins might be more specific for disseminated 
disease than antibodies to cell wall polysaccharide. 
Prior to our efforts, studies using defined antigens 
have been done using the precipitin reaction, as most ag~ 
glutination and classical indirect immunofluorescence 
tests use whole Candida cells as substrate and, thus, 
detect anti-cell wall mannan antibodies. Taschdjian et 
al. (3) prepared a Candida extract, called the S antigen, 
and used it in immunodiffusion. Though the authors ha,\Te 
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called it a "cytoplasmic extract", they describe two 
precipitin lines when the antigen is tested against rabbit 
sera, one of which could be removed by absorption of the 
antiserum with Candida spores. This indicates that the 
extract contains a cell wall component. Precipitins 
against both antigens were found in 83% of patients diag-
nosed as having systemic candidiasis but the same reaction 
was found in patients with chronic cutaneous or mucocutane-
ous candidiasis associated with autoimmune endo~rinopathy. 
The authors claim that no reaction at all was demonstrated 
in normals or patients with banal superficial candidiasis. 
Hellwege et ale (106), using a similar antigen, however, 
found false positive precipitin reactions in three of 93 
healthy individuals and eight of ten patients with bronchial 
asthma. 
Buckley, Lapa, and Hipp (107) removed the polysaccha-
ride from their extract by precipitation with concanavallin 
A and eliminated the positive precipitin reactions of 
eight patients with banal superficial candidiasis ~nd 
three with allergic conditions, while five patients with 
systemic candidiasis and two with chronic superficial 
candidiasis reacted with the protein fraction. Syverson 
et al. (75) found 33 of 271 hospitalized patients without 
evidence of deep candidal infection, six of 22 vaginal 
candidiasis patients, and ten of 41 patients with other 
fungal infections to have positive precipitin reactions 
with an extract containing polysaccharide. After purifica-
103 
tion of the antigen on Con A, only six of the hospitalized 
patients, none of the vaginal candidiasis patients, and 
two of the patients with other fungi reacted. 
In our studies we have also shown that precipitin re-
actions in normals and in patients with cross-reacting 
fungi are indee.d due to the reaction wi th the polysaccha-
ride component. In contrast, precipitating antibodies to 
purified cytoplasmic antigen were found only in patients 
with systemic disease and in one patient with a long-stand-
ing chronic mucocutaneous candidiasis. These results 
confirm that when a qualitative test for precipitating an-
tibodies is used, the use of purified cytoplasmic antigen 
rather than a crude extract COlltaining cell wall poly-
saccharide, provides a much more specific test for systemic 
disease. There is, however, some lack of sensitivity 
since three of a total of 12 (Series I and II) patients 
with systemic disease did not have anti-yeast cytoplasmic 
antibodies and eight of 21 patients did not have anti-myce-
lial cytoplasmic antibodies. This may be partly due to 
these patients having been infected with strains of Candida 
other than albicans as was true with five of our negative 
patients who had been infected with c. tropicalis. But,_ 
since three others were also negative, the difference in 
strains does not entirely account for the lack of sensitivi-
ty. Testing against cytoplasmic extracts from various 
strains, however, might lead to some improvement. 
Our QIF assay has allowed us to combine a quantitative 
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assay with the use of purified antigens and has resulted 
in our finding that antigens containing cell wall polysaccha-
ride can be much more valuable in a quantitative than a 
qualitative assay. statistically, excellent differentia-
tion between systemic patients and normal or superficially 
infected patients is obtained with yeast (p < 0.004) and 
mycelial (p < 0.001) polysaccharide antigens. The speci-
ficity of the test appears better with yeast polysaccharide 
antigen since only one out of 15 superficially infected 
patients and no normal has a value greater than two standard 
deviations above the normal mean. .with myce~ial poly-
saccharide, three superficially infected patients have 
significant levels of antibody. with regard to sensitivity, 
however, mycelial polysaccharide appears better since 13 
of 14 systemic patients have significantly elevated antibody 
values while nine of 14 are positive with yeast polysaccha-
ride. 
When QIF is done using cytoplasmic antigens, the 
specificity is not as great as it appeared with ClE, 
possibly because this technique is more sensitive qnd so 
detects lower levels of anti-cytoplasmic antibody which 
may be present in less severely infected individuals. 
However, all the patients with systemic candidiasis still 
do not have evidence of anti-cytoplasmic antibodies even 
with this technique. A compromised level of immunocompe-
tence in these patients could possibly account for this. 
In summary, our data on the detection of antibodies 
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to Candida suggests that both approaches, quantitation of 
antibody and purification of antigen , can result in im-
provements in the value of these tests in the diagnosis of 
systemic candidiasis. If a qualitative precipitin tech-
nique is used, the use of cytoplasmic antigens provides a 
test more specific for systemic disease. If a quantitative 
test is used, however, the purification of the antigens is 
less essential as adequate differentiation between deeply 
infected patients and others can be attained by antigens 
containing cell wall polysaccharide. In fact, there seems 
to be more overlap between groups when the cytoplasmic an-
tigens are used in the quantitative technique. 
It has also been suggested (45) that, since the myce-
lial form of Candida albicans is thought to be associated 
with severe infections as opposed to saprophytic coloniza-
tion, mycelium specific antigens might also be more speci-
fic for disseminated disease. However, our study has not 
been able to clearly define the value of the mycelial 
growth pha~e antigens as opposed to yeast phase antigens. 
Although more of the systemic patients were found to be 
positive with mycelial antigens than with yeast antigens, 
there also were more positive results with these antigens 
and superficially infected patients. This question remains 
open for discussion. 
It seems apparent that an absolute diagnosis of sys-
temic candidiasis cannot be accomplished through antibody 
detection techniques even though their value is improved 
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by quantitation and antigen purification. 
Many investigators (51, 52, 53, 54) have, therefore, 
turned to detection of circulating antigen as a possible 
means to achieve a more absolute diagnosis. Although some 
have claimed a degree of success, others (55, 56) have 
questioned the helpfulness of these assays. Our difficul-
ties in attempting antigen detection lead us to support 
the latter group_ 
Several ideas have been offered to explain the diffi-
culties with antigen detection. Lehman and Reiss (55) 
have suggested that one problem may be the existence of 
major differences in the sensitivity of anti~mannan sera 
to the two serotypes of c. albicans mannan. They also 
have observed temperature sensitivity which may affect the 
success of the tests, especially when ELISA is used. 
Studies by Warren et ale (108) showed that antigen was not 
detectable when the antibody used was anti-mannan IgG from 
immunized rabbits but that IgG from rabbits convalescing 
from disseminated candidiasis was capable of detecting 
antigen in the sera of lethally infected rabbits and mice. 
This suggests that some antigen other than mannan may be 
what is detected. Jones (56) suggests that the limits of 
detection of the available assays may not be adequate to 
detect extremely small levels of antigen present in the 
sera of infected individuals since declaring a serum 
positive becomes extremely difficult when detection of a 
concentration < 100 ng/ml is necessary. Jones found that 
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cell wall mannan 18 cleared very rapidly from the blood 
and that a disseminated infection with a very large number 
of organisms (~ 109 ) would be necessary to reliably produce 
a mannan concentration> 100 ng/ml in the sera of rabbits. 
When such a large number of organisms is used to induce 
infection, the inoculum is uniformly lethal in less than 
24 hours so that meaningful studies cannot be done. Our 
work agrees with this since three rabbits injected with 
109 organisms and one of two infected with 108 died within 
24 hours. Jones further suggests that ~ 1010 Candida 
would be reqllired to produce > 100. ng/rnl of mannan in 
human serum. 
Finally, those authors (53, 57) who have been success-
ful in detecting circulating antigen have often found it 
necessary to pretreat the sera in such a way that antigen 
would be released from antibody. Weiner and coats-Stephen 
(53) noted that none of 17 rabbit sera not subjected to 
dissociating condi tions had detectable antig"e.n but all had 
detectable antigen after heat extraction of serum bound 
antigen. However, our experiments with a sodium hydroxide 
treatment of mixtures of normal serum and purified antigen 
indicate that subjection of serum to dissociating conditions 
can result in denaturation of antigen and interference 
with detection assays. It seems logical to conclude that 
milder and safer techniques to dissociate antigen-antibody 
complexes may need to be developed for antigen detection 
to become a routine assay. 
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On the other hand, though much has been assumed about 
the presence of immune complexes in candidiasis patients' 
sera, no hard evidence of their existence has been presen-
ted until this time. Results of the screening tests which 
were performed in our group of disseminated candidiasis 
patients indicated a statistically significant difference 
did exist in the levels of complexes in this group and a 
group of normals. Isolation and characterization of the 
complexes from five patients substantiated the presence of 
anti-candida antibody and/or Candida antigen in complexes 
of at least three of them. In the.other two, it was less 
certain as the antibody or antigen was found in the fraction 
which did not bind to Protein A rather than in the IgG 
containing fraction that did bind. However, Candida 
antigen or antibody was found in the high molecular weight 
fraction of these sera and antibody might have been of a 
class other than IgG or of subclass IgG3 which would not 
have bound to Protein A. The presence of complement 
components in the high molecular weight fractions and the 
Protein A bound fractions of these sera further substantia-
ted the existence of immune complexes. 
These results provide support for the view that 
circulating immune complexes containing microbial antigen 
do exist in systemic candidiasis and, therefore, may 
indeed be one reason for difficulties in detecting Candida 
antigen since a variable fraction of the antigenic deter-
minants of circulating antigen will be uhiddenu by binding 
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to antibody molecules. In addition to their significance 
with respect to antigen detection l any possible role of 
immune complexes in the pathogenesis of the disease is un-
known. There is no evidence for any immune-complex-media-
ted vasculitis or glomerulonephritis as is seen in the 
renal lesions of malaria (109) and in post-streptococcal 
glomerulonephritis (110). Another possibility, which has 
been suggested in coccidioidomycosis (10), is that the 
role of immune complexes might be related to their potential 
immunosuppressive effects. Immune complexes have been 
shown to depress T cell-mediated delayed type hypersensitivi-
ty (11) and cell-mediated cytotoxicity (112), and to 
suppress the chemotactic response of polymorphonuclear 
neutrophils (113). Considering the importance of phagocytic 
cells of the body in ingesting Candida and of the cellular 
immune response in defense against fungal infections, it 
seems possible that immune complex-mediated suppression of 
the immune response might have an adverse effect on the 
course of the disease. This is an in~eresting hypothesis 
that may be pursued now that the presence of the immune 
complexes has been established. 
In summary, our studies on the immunological approach 
to the diagnosis of systemic candidiasis have resulted in 
several findings. The development of a quantitative immu-
nofluorescence method of antibody detection provides an 
improved diagnostic test for systemic candidiasis. Our 
studies on the relative merits of cytoplasmic and polysaccha-
110 
ride antigens of the yeast and mycelial phases of Candida 
growth have supported the idea that cytoplasmic antigens 
are more valuable in qualitative tests while polysaccharide 
antigens may be adequate in gu~ntitative tests. Finally, 
our substantiation of the existence of circulating Candida-
anti-candida immune complexes in the sera of patients with 
severe candidiasis supports the theory that these immune 
complexes may be part of the problem with developing a re-
liable antigen-detection assay and provides a hypothetical 
mechanism for the suppression of the cellular immune re-
sponse which may be involved with the progression of the 
disease. 
III 
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